Other symptoms and signs involving cognitive functions and awareness

R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_COGNITIVE_FUNCTIONS_AWARE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R41 Cause of death: ICD-10 — R41 2 out of 7 registries used, show all original rules.	28982
4. Check minimum number of events None	28982
5. Include endpoints None	28982
6. Filter based on genotype QC (FinnGen only)	25724

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_COGNITION_PERCEP_EMOTIONAL_STATE_BEHVI

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R4[0-6]
Name in latin: Aliae symptomata et signa ad cognitionem et vigilantiam pertinentia

NAME	R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_COGNITIVE_FUNCTIONS_AWARE
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_COGNITION_PERCEP_EMOTIONAL_STATE_BEHVI
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R41
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R41
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other symptoms and signs involving cognitive functions and awareness based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Memory loss

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	25724	13463	12261
Unadjusted period prevalence (%)	5.18	4.78	5.62
Median age at first event (years)	68.80	67.15	70.62

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
26431: Matched controls
234180

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

321.8

1971

6887

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.3

320.6

886

1879

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

318.7

6119

33388

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

313.7

3344

14919

U04

ICPC

Incontinence urine

2.6

312.0

1972

6996

SPAT1254

SPAT

Administration of medicine

2.0

311.6

4309

21133

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.5

310.3

803

1616

W19

ICD-10 Finland

Unspecified fall

2.2

309.2

2991

12837

SPAT1216

SPAT

Assessment of functional ability

2.1

307.7

4951

22868

N06DA03

ATC

rivastigmine; oral, transdermal

5.3

307.7

2613

4757

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

13464

86489

G45.4

ICD-10 Finland

Transient global amnesia

4.2

307.7

934

2026

R41.0

ICD-10 Finland

Disorientation, unspecified

141.1

307.7

5793

465

N06AB06

ATC

sertraline; oral

2.5

307.7

3056

11846

N03AG01

ATC

valproic acid; systemic, rectal

5.1

307.7

2674

5024

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.6

307.7

1353

3458

P20

ICPC

Memory disturbance

5.3

307.7

8489

19326

G30.1

ICD-10 Finland

Alzheimer disease with late onset

5.5

307.7

4007

7327

XF606

NOMESCO Finland

Ortostatic test

12.5

307.7

488

352

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.6

307.7

2190

4530

R55

ICD-10 Finland

Syncope and collapse

2.9

307.7

4177

14150

N06AX11

ATC

mirtazapine; oral

2.5

307.7

10959

51666

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

307.7

4753

23014

N05BA01

ATC

diazepam; systemic, rectal

2.3

307.7

3859

16484

N06AX21

ATC

duloxetine; oral

2.6

307.7

3572

13399

G31.0

ICD-10 Finland

Circumscribed brain atrophy

12.7

307.7

338

238

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

307.7

3193

8729

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.3

307.7

1003

2113

N03AX14

ATC

levetiracetam; systemic

4.7

307.7

1242

2420

R42

ICD-10 Finland

Dizziness and giddiness

6.3

307.7

7853

14727

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.2

307.7

2349

6860

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.0

307.7

3018

9540

F06.7

ICD-10 Finland

Mild cognitive disorder

7.0

307.7

1980

2664

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

4.1

307.7

1095

2421

N03AX09

ATC

lamotrigine; oral

4.4

307.7

1567

3314

I95.1

ICD-10 Finland

Orthostatic hypotension

3.9

307.7

1535

3630

SPAT1234

SPAT

Support of social functional capacity

2.8

307.7

1799

5852

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

307.7

1408

4073

N06DA02

ATC

donepezil; oral

5.0

307.7

3626

7180

AXX01

NOMESCO Finland

Memory assessment

17.0

307.7

601

321

P29

ICPC

Psychological sympt/compl other

2.9

307.7

1908

6063

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

307.7

4262

12666

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

4498

21950

F03

ICD-10 Finland

Unspecified dementia

5.1

307.7

2481

4661

R53

ICD-10 Finland

Malaise and fatigue

2.8

307.7

8816

35372

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.5

307.7

966

1599

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.7

307.7

1143

2224

N06AB10

ATC

escitalopram; oral

2.4

307.7

5613

23833

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

307.7

7397

28562

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

307.7

1928

5429

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

5.7

307.7

969

1549

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

307.7

4670

22832

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

157.1

307.7

19898

4453

N06DX01

ATC

memantine; oral

5.3

307.7

4632

9064

N03AX16

ATC

[U] pregabalin

1.9

307.7

6296

33249

N05BA06

ATC

lorazepam; systemic, sublingual

3.0

307.7

1780

5511

R41.3

ICD-10 Finland

Other amnesia

39.9

307.7

4269

1125

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

3.4

307.7

1590

4268

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

307.7

10115

52404

L28

ICPC

Limited function/disability (L)

2.2

307.7

6345

29604

N05AX12

ATC

aripiprazole; systemic

4.5

307.7

1193

2451

SPAT1053

SPAT

Memory test

3.0

307.7

6005

21177

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

3.8

307.7

1560

3826

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

4.1

307.7

1647

3761

TAB00

NOMESCO Finland

Lumbar puncture

7.8

307.7

2443

3008

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.1

307.7

3050

9384

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.8

307.7

3159

8116

A04

ICPC

Weakness/tiredness general

2.4

307.7

5163

21261

N05BA04

ATC

oxazepam; oral

2.3

307.7

8186

37976

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

307.7

7820

44170

N06AB04

ATC

citalopram; systemic

2.4

307.7

6374

27839

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

307.7

3043

11599

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.7

307.7

2066

7127

N06DA04

ATC

galantamine; oral

3.9

307.7

1013

2352

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

8.7

307.7

513

533

N17

ICPC

Vertigo/dizziness

2.6

307.7

3950

14929

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.6

307.7

1601

2674

N05AH04

ATC

quetiapine; oral

3.7

307.7

6751

20082

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.2

307.7

1410

3083

N05CF01

ATC

zopiclone; oral

1.8

307.7

9190

53260

AA1AD

NOMESCO Finland

CT of head and brain

4.2

307.7

12563

41922

P70

ICPC

Dementia

4.5

307.7

1116

2266

N03AE01

ATC

clonazepam; systemic

2.9

307.7

1760

5533

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

10.4

307.7

902

793

S06.0

ICD-10 Finland

Concussion

2.8

307.7

3628

12434

N03AX12

ATC

[U] gabapentin; oral

2.0

307.7

4391

21226

N06AX26

ATC

vortioxetine; oral

3.3

307.7

2380

6725

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.3

307.7

820

1417

Z2445

NOMESCO Finland

Psychologist

6.4

307.7

1602

2329

N02BE01

ATC

paracetamol; systemic, rectal

2.2

307.7

23506

183278

N05AH03

ATC

olanzapine; systemic

4.7

307.7

2520

5171

N06AX16

ATC

venlafaxine; oral

2.7

307.7

4203

15295

G30.0

ICD-10 Finland

Alzheimer disease with early onset

8.3

307.7

549

594

XA800

NOMESCO Finland

Neuropsychological investigation

14.0

307.7

3488

2510

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.6

307.7

3664

13630

G30.8

ICD-10 Finland

Other Alzheimer disease

4.2

307.7

1076

2337

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.5

307.7

1297

3377

A28

ICPC

Limited function/disability NOS

3.0

307.7

7619

27463

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.5

307.7

2326

4898

A06AD11

ATC

lactulose; oral

2.1

307.7

4740

22303

F05.9

ICD-10 Finland

Delirium, unspecified

7.4

307.7

1372

1727

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

307.7

5156

20073

R51.80

ICD-10 Finland

Headache

2.6

307.7

4368

16647

R1250

NOMESCO Finland

Evaluation of functional capability

5.8

307.7

1227

1950

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.7

307.7

2724

9644

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

307.7

2501

6035

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.1

307.7

4332

8693

N03AF02

ATC

oxcarbazepine; oral

5.0

307.7

1370

2546

N05AX08

ATC

risperidone; systemic

4.9

307.7

4422

9285

R40.2

ICD-10 Finland

Coma, unspecified

54.7

307.7

311

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.4

307.7

2807

7800

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

306.8

7977

47374

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

304.7

4411

21958

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.5

304.5

1136

2983

N30.0

ICD-10 Finland

Acute cystitis

1.9

303.3

4626

23429

N06AB03

ATC

fluoxetine; oral

2.1

302.5

3212

14296

C03CA01

ATC

furosemide; systemic

1.7

302.0

9240

57228

Z71.8

ICD-10 Finland

Other specified counselling

1.7

299.2

8504

51640

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

297.1

2186

8333

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

296.8

7644

45197

P03

ICPC

Feeling depressed

2.4

296.5

2306

9013

C07AB07

ATC

bisoprolol; oral

1.6

294.1

13481

92063

N05CD07

ATC

temazepam; oral

2.0

293.7

3589

16822

R5110, ,

SPAT

2.2

292.8

2730

11529

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

288.4

7089

41329

P76

ICPC

Depressive disorder

2.7

283.9

1642

5562

R4110

NOMESCO Finland

Physiotherapy

1.7

283.4

7380

43662

G44.2

ICD-10 Finland

Tension-type headache

2.1

281.3

3221

14725

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.5

277.7

1893

6955

P99

ICPC

Psychological disorders other

3.9

277.7

861

1989

A01

ICPC

Pain general/multiple sites

2.1

277.6

2893

12757

R11

ICD-10 Finland

Nausea and vomiting

2.3

274.3

2362

9638

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.3

270.5

742

1563

N05AN01

ATC

lithium; oral

4.3

269.2

745

1580

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

10.1

265.2

319

282

SPAT1301

SPAT

No procedures

1.6

265.0

8167

50281

S01.0

ICD-10 Finland

Open wound of scalp

2.2

265.0

2414

10078

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

262.6

1942

7405

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

262.4

1458

4832

F01.9

ICD-10 Finland

Vascular dementia, unspecified

4.6

261.9

653

1274

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.0

259.6

785

1780

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

258.0

2684

11809

N06AX12

ATC

bupropion; oral

2.6

256.9

1630

5778

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.3

256.8

2079

8252

R06.0

ICD-10 Finland

Dyspnoea

1.6

254.3

7260

43752

F05.1

ICD-10 Finland

Delirium superimposed on dementia

7.3

251.5

390

479

N05AA02

ATC

levomepromazine; systemic

3.0

251.4

1176

3543

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

251.0

4431

23360

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

6.6

250.2

424

575

A02BC02

ATC

pantoprazole; systemic

1.6

248.7

17597

130515

Z3231

NOMESCO Finland

Registered nurse

1.6

248.0

7088

42677

M54.5

ICD-10 Finland

Low back pain

1.6

247.8

8809

55934

N05AD01

ATC

haloperidol; systemic

3.1

246.8

1088

3165

Z01.9

ICD-10 Finland

Special examination, unspecified

2.5

246.0

1764

6626

N06AA09

ATC

amitriptyline; systemic

2.1

244.3

2591

11474

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

243.9

8808

56084

Z3226

NOMESCO Finland

Physiotherapist

1.8

242.4

4668

25230

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.4

242.2

644

1323

R41.2

ICD-10 Finland

Retrograde amnesia

46.3

241.0

156

AXX01, ,

SPAT

2.7

239.8

1405

4782

N03AF01

ATC

carbamazepine; oral, rectal

2.6

239.6

1482

5184

N02AA05

ATC

oxycodone; systemic

1.7

239.1

5318

29927

B01AC04

ATC

clopidogrel; oral

1.8

239.0

4687

25453

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.1

238.7

530

936

183

Kela drug reimbursment

Lamotrigin and topiramate

7.7

238.1

351

406

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

238.0

1426

4909

G30

ICD-10 Finland

Alzheimer disease

5.0

237.9

542

979

Z2221

NOMESCO Finland

Medical doctor

1.6

237.8

6739

40412

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

237.2

3872

19892

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

237.1

2120

8767

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

8.7

236.0

316

324

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.8

235.6

765

1825

ZXY02

NOMESCO Finland

Neuropsychologist

11.0

235.5

268

218

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

235.3

2054

8409

F34.1

ICD-10 Finland

Dysthymia

3.2

233.6

974

2739

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

233.3

7395

45547

M79.6

ICD-10 Finland

Pain in limb

1.5

233.1

10757

72191

C10AA01

ATC

simvastatin; oral

1.5

233.0

11510

78396

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.9

230.8

1157

3622

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.6

230.0

1462

5181

C07AA05

ATC

propranolol; systemic

1.8

229.9

4632

25320

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

228.0

3770

19427

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

227.4

4777

26415

F05.8

ICD-10 Finland

Other delirium

6.7

226.4

379

507

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.2

226.4

411

599

A29

ICPC

General symptom/complaint other

1.8

224.2

3725

19215

L17

ICPC

Foot/toe symptom/complaint

1.6

222.2

7809

49165

N06AX03

ATC

mianserin; oral

2.6

221.9

1392

4900

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.8

221.3

1156

3701

Z2446

NOMESCO Finland

Social worker

2.4

219.7

1681

6494

P01

ICPC

Feeling anxious/nervous/tense

2.1

219.6

2425

10883

G04BD12

ATC

mirabegron; oral

1.9

219.4

3442

17428

SPAT1240

SPAT

Therapeutic discussion

2.1

218.8

2241

9773

R44.1

ICD-10 Finland

Visual hallucinations

14.8

218.5

209

126

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

218.2

4794

26805

N03AX18

ATC

lacosamide; systemic

7.0

218.2

349

444

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

217.9

2000

8349

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.3

217.6

886

2454

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

215.3

8968

58565

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.9

214.9

1076

3365

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.7

211.4

521

1006

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

207.2

2685

12747

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.8

205.6

1118

3655

N05AB03

ATC

perphenazine; systemic, rectal

3.0

205.4

954

2858

R4120

NOMESCO Finland

Occupational therapy

2.3

204.4

1756

7127

R44.3

ICD-10 Finland

Hallucinations, unspecified

15.3

203.5

191

111

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.4

203.2

426

714

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

201.8

5747

34279

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.4

201.2

534

1095

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.8

201.2

478

895

N01

ICPC

Headache

2.0

200.6

2389

11005

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

199.6

1188

4069

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

197.9

1885

7978

K59.0

ICD-10 Finland

Constipation

2.3

196.1

1668

6738

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

195.2

16420

122843

N05AF03

ATC

chlorprothixene; systemic

3.5

194.3

724

1895

A11

ICPC

Chest pain NOS

2.0

193.8

2360

10951

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

193.6

6420

39638

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

193.1

2213

10048

OAB76

NOMESCO Finland

General guidance on nutrition and food

10.6

192.8

224

188

R40.0

ICD-10 Finland

Somnolence

37.3

191.2

130

D12

ICPC

Constipation

2.6

191.1

1172

4074

N05BA12

ATC

alprazolam; oral

2.0

190.5

2425

11426

J01DB01

ATC

cefalexin; oral

1.6

188.5

20572

161829

N05CF02

ATC

zolpidem; oral

1.7

188.5

4106

22806

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

25.5

188.3

143

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.8

187.9

447

838

N02AX02

ATC

tramadol; systemic, rectal

1.5

187.0

10842

75175

J01EA01

ATC

trimethoprim; systemic

1.6

186.9

6285

38878

R25.1

ICD-10 Finland

Tremor, unspecified

2.9

186.5

945

2972

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.1

186.1

2050

9167

C10AA05

ATC

atorvastatin; oral

1.5

185.9

11145

77751

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.1

185.8

537

1176

A02BC03

ATC

lansoprazole; oral

1.5

182.0

7085

45224

R60.0

ICD-10 Finland

Localized oedema

1.8

181.3

3463

18525

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.5

180.8

1186

4259

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.8

180.2

423

784

J01MA02

ATC

ciprofloxacin; systemic

1.5

179.9

9934

68066

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

179.4

5405

32545

G40

ICD-10 Finland

Epilepsy

5.9

177.7

336

510

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

177.7

8704

58207

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

177.2

10765

75062

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.9

177.1

406

737

ZXA00

NOMESCO Finland

Right side

1.5

176.6

6609

41775

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.3

176.3

372

627

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

4.0

175.8

525

1178

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

6.1

175.3

319

466

PA6AD

NOMESCO Finland

CT of neck arteries

2.7

175.2

1040

3554

SPAT1360

SPAT

Extensive global examination

2.1

174.5

1899

8447

WX892

NOMESCO Finland

Monitored bed care

2.0

174.5

2083

9583

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.9

173.2

398

724

SPAT1229

SPAT

Assessment of need for aid

2.0

172.6

2106

9763

R02

ICPC

Shortness of breath/dyspnoea

1.7

172.3

3566

19489

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

172.3

7743

50815

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

172.1

1238

4640

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

170.9

1732

7497

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.3

170.8

471

995

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.1

170.7

500

1106

ZXA05

NOMESCO Finland

Left side

1.5

170.4

6185

38783

WX002

NOMESCO Finland

Sedation and analgesia

1.6

170.1

4822

28570

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.1

169.9

775

2296

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.4

169.4

1286

4938

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

169.3

2484

12250

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.9

169.3

392

718

N88

ICPC

Epilepsy

7.1

169.2

269

340

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.6

169.0

582

1445

N03AX11

ATC

topiramate; oral

3.6

168.5

589

1477

P74

ICPC

Anxiety disorder/anxiety state

2.7

168.5

952

3172

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.3

168.0

298

424

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

167.9

6676

42667

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.6

167.9

574

1418

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

4.1

167.4

484

1060

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.2

167.1

467

997

S18

ICPC

Laceration/cut

1.4

166.6

11853

84780

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

165.7

4444

25958

F32

ICD-10 Finland

Depressive episode

2.4

165.3

1200

4515

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

5.3

165.0

351

596

N07BB01

ATC

disulfiram; oral

2.6

165.0

1047

3698

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

164.2

3160

16907

C08CA01

ATC

amlodipine; oral

1.4

163.0

10114

70458

N05BE01

ATC

buspirone; oral

3.0

162.8

776

2357

A02BC05

ATC

esomeprazole; systemic

1.4

162.5

9689

66990

L03

ICPC

Low back symptom/complaint

1.5

162.2

6771

43656

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

12.0

162.0

174

129

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.0

161.7

476

1057

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.8

160.4

521

1242

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.1

159.7

699

2021

N05AH02

ATC

clozapine; systemic

4.2

159.5

453

979

R52.9

ICD-10 Finland

Pain, unspecified

1.8

158.8

2545

12890

R35

ICD-10 Finland

Polyuria

2.0

157.3

1895

8734

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

157.3

10358

72795

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

157.1

4380

25789

N27

ICPC

Fear of neurological disease other

3.5

156.2

575

1492

F61.0

ICD-10 Finland

Mixed personality disorders

4.3

155.7

425

891

F22.0

ICD-10 Finland

Delusional disorder

4.1

155.2

454

1003

A27

ICPC

Fear of other disease NOS

2.2

155.1

1376

5644

ZY010

NOMESCO Finland

Hospital outpatient

2.4

154.7

1137

4300

P15

ICPC

Chronic alcohol abuse

2.9

154.7

773

2411

J01CA08

ATC

pivmecillinam; oral

1.4

154.3

8857

60644

OAB48

NOMESCO Finland

Lifestyle advice and guidance

8.3

154.1

214

230

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

154.0

2862

15141

N29

ICPC

Neurological sympt/complt other

3.3

152.9

595

1600

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

152.2

660

1897

R52.2

ICD-10 Finland

Other chronic pain

2.6

152.2

959

3374

S00.0

ICD-10 Finland

Superficial injury of scalp

3.0

151.7

707

2120

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

151.6

1723

7775

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.9

150.6

345

626

SPAT1101

SPAT

Orthostatic test

2.3

150.3

1203

4724

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.2

150.0

637

1808

F01.2

ICD-10 Finland

Subcortical vascular dementia

7.1

149.9

236

295

AA400

NOMESCO Finland

Electroconvulsive therapy

6.3

149.8

266

379

P06

ICPC

Sleep disturbance

1.7

149.2

2886

15434

R07.3

ICD-10 Finland

Other chest pain

1.8

147.2

2530

13072

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

146.2

8996

62219

WYA20

NOMESCO Finland

Home visit

3.2

145.7

609

1712

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.9

145.4

702

2147

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.4

145.4

303

505

N06AG02

ATC

moclobemide; oral

2.4

145.4

1108

4258

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

145.2

2244

11223

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

8.8

145.0

192

194

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

144.7

1607

7187

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.9

144.2

334

612

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

144.0

2130

10506

N06AB05

ATC

paroxetine; oral

2.2

143.9

1344

5626

R13

ICD-10 Finland

Dysphagia

2.0

143.7

1804

8427

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

143.5

6493

42360

E86

ICD-10 Finland

Volume depletion

2.8

143.4

784

2566

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

5.4

143.1

297

493

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

143.1

16399

125970

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

142.8

2515

13084

D11

ICPC

Diarrhoea

1.8

142.1

2606

13715

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

142.1

1113

4328

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.6

141.5

350

678

U02

ICPC

Urinary frequency/urgency

1.6

140.6

3569

20486

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

140.5

3014

16565

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.0

139.8

417

935

SPAT1263

SPAT

Sampling

1.4

139.2

9761

68913

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.3

138.7

546

1479

M79.7

ICD-10 Finland

Fibromyalgia

2.7

138.5

802

2704

G04BD08

ATC

solifenacin; oral

2.0

138.4

1753

8210

G47.3

ICD-10 Finland

Sleep apnoea

1.5

138.4

5352

33784

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

138.3

9504

66840

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

3.7

137.8

450

1077

U07

ICPC

Urine symptom/complaint other

1.8

137.4

2221

11255

B01AA03

ATC

warfarin; systemic

1.5

137.1

5110

32001

C01DA14

ATC

isosorbide mononitrate; oral

1.6

136.6

4316

26069

S70.0

ICD-10 Finland

Contusion of hip

2.3

136.6

1085

4244

IGV01

NOMESCO Finland

Psychiatric network contact

5.8

136.5

264

410

N04AA02

ATC

biperiden; systemic

3.4

136.4

522

1389

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.9

136.1

694

2188

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

135.3

3229

18235

E0000UV, ,

ATC

1.4

135.0

9774

69275

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

134.8

2293

11798

UJF32

NOMESCO Finland

Coloscopy

1.5

134.5

6507

42904

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

134.5

1093

4317

A02BC01

ATC

omeprazole; systemic

1.5

133.9

6572

43448

XF404

NOMESCO Finland

Ambulatory ECG

1.8

133.5

2132

10761

SPAT1252

SPAT

Overall medication plan or its review

1.9

133.3

1794

8574

M48.0

ICD-10 Finland

Spinal stenosis

1.6

132.5

3222

18274

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

132.5

7069

47447

N06AX05

ATC

trazodone; oral

3.0

132.1

620

1866

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

131.5

3170

17936

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

131.5

587

1716

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

131.1

16686

129409

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

130.7

1898

9296

S22.3

ICD-10 Finland

Fracture of rib

1.9

130.7

1833

8878

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.8

129.7

305

566

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

129.0

482

1263

C09AA05

ATC

ramipril; oral

1.4

128.8

6442

42681

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.4

128.8

965

3678

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

128.2

4456

27443

ZY000

NOMESCO Finland

Hospital inpatient

4.5

128.0

330

661

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

127.8

10185

73144

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

127.7

1082

4348

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

127.4

1307

5669

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.3

126.8

269

456

K90

ICPC

Stroke/cerebrovascular accident

2.5

126.7

835

3000

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.8

126.5

185

212

ZXD05

NOMESCO Finland

Urgent procedure

1.4

126.4

6907

46482

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

126.1

3017

17026

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

124.9

3367

19563

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.2

124.9

353

760

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

124.7

5831

38107

F31

ICD-10 Finland

Bipolar affective disorder

4.4

124.6

326

661

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

123.6

8651

60717

R50.9

ICD-10 Finland

Fever, unspecified

1.6

123.6

3613

21393

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.3

123.0

494

1355

N06AX22

ATC

agomelatine; oral

3.2

122.5

519

1471

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.7

122.3

401

962

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

122.3

4026

24480

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

122.1

808

2908

M25.5

ICD-10 Finland

Pain in joint

1.4

122.1

7145

48614

SPAT1260

SPAT

Consultation of another employee

1.5

121.9

4149

25408

N04BC05

ATC

pramipexole; oral

1.8

121.2

1897

9505

UKC02

NOMESCO Finland

Cystoscopy

1.5

121.1

4159

25514

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.5

121.1

243

391

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

121.0

3077

17618

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.4

120.6

314

634

K02.1

ICD-10 Finland

Caries of dentine

1.4

120.2

13011

97706

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.2

120.0

337

722

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.6

120.0

301

590

KMAK, ,

NOMESCO Finland

1.4

119.8

10885

79549

R41.1

ICD-10 Finland

Anterograde amnesia

59.8

119.5

A97

ICPC

No disease

1.5

119.4

4776

30236

Z00.0

ICD-10 Finland

General medical examination

1.5

119.3

4560

28603

R33

ICD-10 Finland

Retention of urine

1.7

118.9

2206

11620

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

118.7

3981

24286

L12

ICPC

Hand/finger symptom/complaint

1.5

118.4

3889

23619

P18

ICPC

Medication abuse

6.1

118.3

214

311

R03AC02

ATC

salbutamol; inhalant

1.4

118.0

12497

93428

G40.10

ICD-10 Finland

Simple partial seizures

5.1

117.7

257

447

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

117.6

2639

14634

N06AA12

ATC

doxepin; systemic

2.1

117.5

1261

5559

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

116.5

1533

7262

EBA00

NOMESCO Finland

Extraction of tooth

1.4

116.2

8201

57487

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

116.1

3960

24237

A02BA02

ATC

ranitidine; systemic

1.5

115.6

4559

28755

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

115.5

1162

4999

XF402

NOMESCO Finland

ECG with work load test

1.7

115.5

2532

13953

R4150

NOMESCO Finland

Neuropsychological rehabilitation

5.5

115.4

232

374

ZXD35

NOMESCO Finland

Usual procedure

2.4

115.4

859

3263

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.8

115.0

220

338

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

114.8

1799

9012

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

13.7

114.6

114

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.2

114.6

1065

4443

N02BF02

ATC

pregabalin; oral

1.9

114.4

1600

7731

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

113.8

3039

17588

G72.8

ICD-10 Finland

Other specified myopathies

3.1

113.6

499

1445

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

4.0

113.5

338

757

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

113.4

1161

5028

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.1

112.6

496

1439

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

112.5

4672

29753

R43.0

ICD-10 Finland

Anosmia

12.1

112.5

120

N02BF01

ATC

gabapentin; oral

1.7

112.4

2403

13149

U13

ICPC

Bladder symptom/complaint other

2.4

111.7

788

2921

G04CA02

ATC

tamsulosin; oral

1.4

110.8

6244

42064

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

110.8

3252

19234

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.6

110.6

219

348

E87.6

ICD-10 Finland

Hypokalaemia

2.3

110.6

925

3695

-1, ,

NOMESCO Finland

1.4

110.4

6821

46682

F32.8

ICD-10 Finland

Other depressive episodes

3.5

110.0

388

979

H03AA01

ATC

levothyroxine sodium; systemic

1.4

109.9

5212

34028

D01

ICPC

Abdominal pain/cramps general

1.6

109.9

2634

14839

F10.24

ICD-10 Finland

Alcohol depence active use

3.5

109.7

391

993

N05BA09

ATC

clobazam; oral

6.4

109.6

190

264

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.9

109.6

252

459

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

108.8

8590

61143

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

108.8

1098

4728

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

108.5

3931

24333

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

108.5

2799

16055

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

108.4

4368

27627

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.9

108.1

546

1712

OAB43, ,

SPAT

0.6

107.8

2381

32562

N28

ICPC

Limited function/disability (N)

3.0

107.7

488

1439

H81.3

ICD-10 Finland

Other peripheral vertigo

2.8

107.7

568

1823

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

107.7

5674

37744

K08.3

ICD-10 Finland

Retained dental root

1.7

107.6

1953

10212

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

106.8

3278

19571

P27

ICPC

Fear of mental disorder

4.0

106.7

315

701

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.5

106.5

387

996

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

106.1

1929

10088

S09.9

ICD-10 Finland

Unspecified injury of head

3.2

106.0

433

1200

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

106.0

12237

92081

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

105.9

647

2239

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

16.4

105.8

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.6

105.7

261

505

R51

ICD-10 Finland

Headache

2.1

105.4

1111

4862

A86

ICD-10 Finland

Unspecified viral encephalitis

6.4

105.0

182

253

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.2

104.9

295

633

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

104.8

3150

18712

SPAT1172

SPAT

Guidance concerning hydration

2.5

104.4

688

2470

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

104.3

955

3959

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

104.2

5904

39740

XA400

NOMESCO Finland

EEG

5.5

104.1

211

343

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

103.9

1318

6162

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.0

103.5

478

1425

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

103.3

1192

5392

R44.0

ICD-10 Finland

Auditory hallucinations

10.6

103.1

120

101

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.1

102.9

456

1327

R63.4

ICD-10 Finland

Abnormal weight loss

2.1

102.8

1046

4517

F80.1

ICD-10 Finland

Expressive language disorder

4.5

102.4

259

511

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

102.3

1476

7199

H53.2

ICD-10 Finland

Diplopia

2.4

102.1

775

2968

M02AA07

ATC

piroxicam; topical

1.4

101.5

8377

59872

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.9

101.1

189

284

W10

ICD-10 Finland

Fall on and from stairs and steps

2.0

100.9

1259

5851

R4130

NOMESCO Finland

Speech therapy

2.5

100.7

665

2390

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.7

100.5

570

1900

A99

ICPC

Disease/condition unspecnature/site

1.6

100.3

2497

14181

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

100.3

2952

17440

SPAT1050

SPAT

Extensive neurological examination

2.8

100.3

525

1678

G20

ICD-10 Finland

Parkinson disease

2.2

100.0

890

3646

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

99.4

1288

6062

U05

ICPC

Urination problems other

1.9

99.3

1365

6552

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

99.2

1087

4825

S29

ICPC

Skin symptom/complaint other

1.4

99.2

4830

31608

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.4

98.5

260

531

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

98.4

5803

39266

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

98.3

1321

6293

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

98.3

1081

4805

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

97.2

3720

23238

SFA10

NOMESCO Finland

One-surface restoration

1.3

97.0

12066

91308

L01

ICPC

Neck symptom/complaint

1.5

96.7

3372

20662

A46

ICD-10 Finland

Erysipelas

1.5

96.5

3697

23096

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

7.4

96.0

147

178

Z01.7

ICD-10 Finland

Laboratory examination

1.5

95.7

3727

23356

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

95.7

639

2309

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

5.6

95.6

188

297

M79.1

ICD-10 Finland

Myalgia

1.5

94.7

3056

18412

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

93.8

1430

7091

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

14.5

93.4

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

93.2

734

2856

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

93.2

2335

13272

P72

ICPC

Schizophrenia

3.1

92.8

412

1201

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

92.6

419

1235

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

92.5

2126

11826

X58

ICD-10 Finland

Exposure to other specified factors

1.5

92.3

3124

19008

Z29

ICPC

Social problem NOS

2.7

92.2

513

1693

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.6

91.7

315

781

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

91.6

6467

44966

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

91.5

2271

12874

R06.4

ICD-10 Finland

Hyperventilation

3.3

90.9

360

979

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

90.6

2343

13414

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

4.1

90.5

261

571

D09

ICPC

Nausea

2.1

90.3

915

3943

B01AC07

ATC

dipyridamole; systemic

1.9

90.0

1121

5203

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

90.0

4473

29314

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

89.9

1976

10864

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

5.0

89.7

201

358

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.3

89.7

239

492

WX212

NOMESCO Finland

Femoral plexus blockade

2.4

89.6

663

2511

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.5

88.8

225

445

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

5.1

88.5

194

339

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.3

88.5

713

2802

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

88.5

2552

14984

ICB01, ,

SPAT

4.3

88.3

240

502

R06AE07

ATC

cetirizine; oral

1.3

88.3

9443

69685

R32

ICD-10 Finland

Unspecified urinary incontinence

2.3

88.1

714

2813

G04BD07

ATC

tolterodine; oral

1.9

88.0

1179

5608

ZXE00

NOMESCO Finland

One hour or less

1.3

88.0

8648

63068

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

87.9

3635

23013

R47.0

ICD-10 Finland

Dysphasia and aphasia

3.5

87.8

314

800

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.1

87.7

377

1078

J01FA06

ATC

roxithromycin; oral

1.3

87.7

8769

64095

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

87.6

2531

14863

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.5

87.5

564

2004

N06AB08

ATC

fluvoxamine; oral

2.4

87.2

607

2236

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.3

87.1

726

2894

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

86.6

6062

42029

H81

ICPC

Excessive ear wax

1.4

86.5

4313

28260

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

5.9

86.5

162

244

SPAT1139

SPAT

Nutrition survey

2.2

86.5

811

3392

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

7.9

86.4

124

139

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

86.4

14516

113576

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

86.4

6318

44099

B01AB05

ATC

enoxaparin; parenteral

1.3

86.0

7432

53174

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

20.3

86.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

85.9

2732

16385

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

85.9

6562

46099

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.0

85.9

387

1138

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.4

85.8

223

450

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

85.7

4368

28726

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

85.6

2215

12674

A10AB05

ATC

insulin aspart; parenteral

1.7

85.3

1768

9568

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.9

85.1

412

1262

R05

ICPC

Cough

1.4

84.8

5458

37319

J01DA01

ATC

[U] cefalexin

1.3

84.8

14200

110925

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

84.6

2741

16500

A98

ICPC

Health maint/preventive medicine

1.5

84.4

23935

201968

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

84.3

385

1141

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.8

84.3

270

638

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

6.7

83.9

140

187

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

83.6

8069

58587

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

83.3

1706

9200

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.2

83.3

351

992

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

82.9

4235

27843

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

82.9

1259

6231

ZXD20

NOMESCO Finland

Day surgery

1.5

82.7

2738

16557

N99

ICPC

Neurological disease other

3.2

82.6

344

965

J01AA02

ATC

doxycycline; systemic

1.3

82.6

18617

150930

A23

ICPC

Risk factor NOS

1.6

82.2

1959

10985

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

82.1

3164

19733

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

82.1

3053

18907

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

82.1

4401

29176

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.1

81.7

781

3290

IGY02, ,

SPAT

3.2

81.7

334

927

SPAT1310

SPAT

Counselling related to known health issue

1.3

81.6

6953

49566

ZXA10

NOMESCO Finland

Bilateral

1.4

81.4

4236

27933

S80.0

ICD-10 Finland

Contusion of knee

1.7

81.4

1579

8391

Z08

ICPC

Social welfare problem

3.2

81.3

335

934

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

81.2

822

3541

P01AB01

ATC

metronidazole; oral, rectal

1.3

81.0

8621

63365

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

80.8

2310

13520

N03AX23

ATC

brivaracetam; systemic

8.6

80.8

109

113

SPAT1246

SPAT

Screening of depression or other psychiatric problem

2.2

80.8

690

2779

I95.9

ICD-10 Finland

Hypotension, unspecified

2.8

80.6

417

1325

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.4

80.3

166

275

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

80.2

808

3473

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

80.2

710

2902

S21

ICPC

Skin texture symptom/complaint

1.4

80.2

3513

22452

S20.2

ICD-10 Finland

Contusion of thorax

1.8

80.0

1206

5953

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.3

80.0

669

2671

N06AA06

ATC

trimipramine; systemic

2.4

79.9

550

2015

S06.3

ICD-10 Finland

Focal brain injury

3.1

79.9

353

1026

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

7.1

79.9

126

158

F21, ,

ICPC

3.8

79.9

250

581

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

79.8

3183

19978

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

79.5

2073

11874

T74.1

ICD-10 Finland

Physical abuse

3.0

79.5

357

1048

C07AB02

ATC

metoprolol; systemic

1.4

79.5

4897

33203

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

79.2

1810

10040

S97

ICPC

Chronic ulcer skin

1.7

79.0

1602

8613

F06.0

ICD-10 Finland

Organic hallucinosis

8.4

79.0

108

114

S16

ICPC

Bruise/contusion

2.1

78.9

768

3258

Z00.8

ICD-10 Finland

Other general examinations

1.7

78.9

1744

9592

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

78.8

9442

70427

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.4

78.6

557

2068

N05BA02

ATC

chlordiazepoxide; systemic

2.4

78.5

558

2075

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

78.5

1396

7239

R15

ICD-10 Finland

Faecal incontinence

2.2

78.3

690

2814

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.8

78.2

250

590

N19

ICPC

Speech disorder

3.0

78.1

361

1077

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

78.0

1118

5432

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

78.0

456

1544

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

6.5

77.9

133

182

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

7.1

77.8

122

152

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

9.6

77.3

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.8

77.2

242

563

IHA21

NOMESCO Finland

Mini-intervention for hazardous and harmful alcohol use

11.9

76.9

F00

ICD-10 Finland

Dementia in Alzheimer disease

6.5

76.9

131

179

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

76.8

7952

58129

N06AA10

ATC

nortriptyline; systemic

2.6

76.8

460

1577

A03FA02

ATC

cisapride; oral, rectal

1.7

76.5

1696

9332

A05

ICPC

Feeling ill

1.8

76.2

1142

5626

SPAT1167

SPAT

Insertion of urinary catheter

2.0

76.2

827

3655

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.7

75.8

437

1469

B01AF02

ATC

apixaban; oral

1.4

75.1

3365

21571

EBA30

NOMESCO Finland

Extraction of root of tooth

1.7

75.0

1358

7076

H02

ICPC

Hearing complaint

1.4

74.9

3575

23180

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.1

74.9

322

921

IHZ05, ,

SPAT

2.1

74.9

730

3099

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

74.8

4514

30464

N06BA04

ATC

methylphenidate; oral

2.5

74.8

480

1702

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.2

74.7

314

886

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

74.5

2465

14882

R05

ICD-10 Finland

Cough

1.4

74.5

4663

31651

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

74.5

1404

7397

H02AA02

ATC

fludrocortisone; oral

3.8

74.4

240

570

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

74.4

1522

8199

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

5.6

74.2

147

234

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

74.1

1217

6164

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

7.1

74.1

117

147

J01CA04

ATC

amoxicillin; systemic

1.3

73.9

19088

156077

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.7

73.9

242

581

AN1

Coronary angiography

1.5

73.9

2633

16144

D07AA02

ATC

hydrocortisone; topical

1.5

73.8

2799

17375

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

73.8

2233

13224

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.3

73.8

557

2128

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

73.8

3812

25061

K85

ICPC

Elevated blood pressure

1.4

73.4

3966

26270

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

73.4

3010

18973

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.1

73.3

322

933

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

73.2

884

4057

N03AB02

ATC

phenytoin; systemic

3.2

73.1

307

866

P16

ICPC

Acute alcohol abuse

2.9

73.1

360

1114

K91

ICPC

Cerebrovascular disease

2.8

73.0

373

1177

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

72.7

809

3607

SPAT1251

SPAT

Organisation of medication

2.0

72.6

822

3689

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

72.5

705

2989

A08

ICPC

Swelling

1.7

72.5

1384

7316

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

6.3

72.4

128

182

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.4

72.2

513

1908

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

72.0

991

4751

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

72.0

1595

8770

L04

ICPC

Chest symptom/complaint

1.7

71.9

1365

7205

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.0

71.8

333

996

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

71.6

4406

29805

G25.0

ICD-10 Finland

Essential tremor

2.2

71.6

644

2649

D07AC01

ATC

betamethasone; topical

1.3

71.5

8217

60754

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

4.7

71.3

170

320

P80

ICPC

Personality disorder

5.9

70.8

132

198

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

70.7

888

4130

J45

ICD-10 Finland

Asthma

1.5

70.7

2148

12728

A01AB09

ATC

miconazole; local oral

1.6

70.7

1874

10767

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

70.5

3277

21128

N80

ICPC

Head injury other

2.5

70.5

476

1729

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.0

70.5

205

452

SPAT1097

SPAT

Recording of ECG

1.4

70.4

3280

21159

J01FF01

ATC

clindamycin; systemic

1.3

70.1

5892

41751

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

70.0

4835

33283

XKD00

NOMESCO Finland

Uroflowmetry

1.4

69.9

3845

25524

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.6

69.8

438

1536

Y94.0

ICD-10 Finland

Accident at home

2.5

69.7

470

1706

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

69.5

829

3788

N07CA01

ATC

betahistine; oral

1.7

69.5

1401

7514

IHZ04, ,

SPAT

2.9

69.2

333

1017

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

69.1

2441

14926

N05AL01

ATC

sulpiride; systemic

2.8

69.1

349

1095

G04CB01

ATC

finasteride; oral

1.5

69.0

2788

17511

P98

ICPC

Psychosis NOS/other

4.7

69.0

166

315

D10

ICPC

Vomiting

1.9

68.7

977

4734

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

68.7

1279

6714

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

68.3

1705

9652

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.4

68.3

259

686

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

68.3

1012

4967

G43.3

ICD-10 Finland

Complicated migraine

3.1

68.2

295

847

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

68.2

5937

42246

L13

ICPC

Hip symptom/complaint

1.4

68.1

4398

29952

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

67.9

2175

13029

K07

ICPC

Swollen ankles/oedema

1.7

67.7

1191

6153

OAA67, ,

SPAT

0.6

67.6

1215

17648

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

67.5

1425

7737

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.9

67.4

155

283

Z72.2

ICD-10 Finland

Drug use

5.7

67.3

130

202

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

67.3

1695

9617

A06AC51

ATC

ispaghula, combinations; oral

1.8

67.1

1040

5176

P28

ICPC

Limited function/disability (P)

3.8

67.0

213

501

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

66.6

591

2417

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

66.5

5454

38465

M01AX05

ATC

glucosamine; oral

1.4

66.4

4479

30693

XKC03

NOMESCO Finland

Water cystometry

2.1

66.3

682

2955

H02AB06

ATC

prednisolone; systemic

1.3

66.2

11041

85144

SFA30

NOMESCO Finland

Three-surface restoration

1.3

66.1

9086

68501

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

66.0

5694

40434

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

65.9

1529

8501

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

65.8

11331

87684

A10AE04

ATC

insulin glargine; parenteral

1.5

65.7

2175

13117

AA1BG, ,

SPAT

2.5

65.4

434

1564

EB1AA, ,

SPAT

1.7

65.3

1282

6827

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.7

65.0

355

1161

K89

ICPC

Transient cerebral ischaemia

3.1

65.0

281

807

R31

ICD-10 Finland

Unspecified haematuria

1.5

65.0

2508

15601

R52.1

ICD-10 Finland

Chronic intractable pain

3.5

64.9

231

587

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

64.8

939

4576

M54.2

ICD-10 Finland

Cervicalgia

1.6

64.8

1569

8816

F41.00

ICD-10 Finland

Moderate panic disorder

3.1

64.7

281

809

WX704

NOMESCO Finland

Intubation

1.6

64.7

1771

10243

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

64.5

1554

8720

G40.89

ICD-10 Finland

Other epilepsy

5.0

64.4

143

253

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

64.1

5817

41571

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.0

63.9

191

430

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

63.9

1910

11268

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.8

63.9

1104

5673

U01

ICPC

Dysuria/painful urination

1.6

63.6

1624

9239

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

9.1

63.6

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

4.0

63.5

190

428

WX872

NOMESCO Finland

Intensive care

1.7

63.4

1169

6117

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

5.4

63.4

129

211

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

63.2

2000

11943

J02AC01

ATC

fluconazole; systemic

1.3

63.1

7729

57375

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

62.9

915

4463

P19

ICPC

Drug abuse

4.0

62.9

187

419

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

62.9

1670

9588

R45.1

ICD-10 Finland

Restlessness and agitation

8.8

62.7

L02

ICPC

Back symptom/complaint

1.5

62.6

1996

11937

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

62.4

8968

67833

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

62.4

1983

11852

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

3.9

62.3

193

446

DFF59

NOMESCO Finland

Other assessment of balance

5.1

62.3

135

234

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.5

62.1

217

545

R03BA02

ATC

budesonide; inhalant

1.4

62.1

3696

24809

L84

ICD-10 Finland

Corns and callosities

1.9

62.0

793

3710

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

62.0

778

3618

I20.09

ICD-10 Finland

Unstable angina

1.7

61.9

1325

7216

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

61.8

2053

12383

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.0

61.8

709

3196

F05

ICPC

Visual disturbance other

2.0

61.8

723

3282

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.9

61.8

816

3860

M01AX17

ATC

nimesulide; oral

1.3

61.7

5271

37326

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.1

61.7

174

375

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

5.6

61.7

121

191

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.3

61.6

245

669

R52.0

ICD-10 Finland

Acute pain

2.0

61.4

667

2948

G93.4

ICD-10 Finland

Encephalopathy, unspecified

6.3

61.4

107

150

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

61.1

4644

32341

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

61.1

2811

18058

K92.1

ICD-10 Finland

Melaena

1.7

61.0

1287

6983

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.1

60.8

263

756

XCK00

NOMESCO Finland

Perimetry

1.6

60.6

1386

7674

U71

ICPC

Cystitis/urinary infection other

1.6

60.6

1434

8008

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

60.6

2409

15061

H01

ICPC

Ear pain/earache

1.5

60.5

2236

13780

I49.5

ICD-10 Finland

Sick sinus syndrome

1.8

60.5

913

4506

D06

ICPC

Abdominal pain localized other

1.5

60.4

1824

10777

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.2

60.1

536

2197

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

59.9

5504

39337

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

59.9

2838

18322

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

59.7

8229

61853

H81.0

ICD-10 Finland

Ménière disease

2.5

59.7

394

1416

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

59.7

2301

14297

F29

ICPC

Eye symptom/complaint other

1.5

59.7

2211

13633

Z03

ICPC

Housing/neighbourhood problem

3.9

59.6

182

416

N30

ICD-10 Finland

Cystitis

1.6

59.6

1608

9263

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

59.6

4067

27866

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.9

59.4

135

244

F01

ICD-10 Finland

Vascular dementia

5.3

59.4

125

211

R25.2

ICD-10 Finland

Cramp and spasm

2.2

59.1

544

2258

SFA20

NOMESCO Finland

Two-surface restoration

1.2

59.0

12339

97093

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

58.9

5425

38772

J46

ICD-10 Finland

Status asthmaticus

2.1

58.9

612

2661

A13

ICPC

Concern/fear medical treatment

2.3

58.9

464

1807

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.2

58.8

248

702

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

58.7

1963

11852

N05CD08

ATC

midazolam; nasal, systemic

2.2

58.6

543

2260

R01AD09

ATC

mometasone; nasal

1.2

58.6

9224

70355

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.2

58.6

519

2122

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

58.6

1452

8200

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.8

58.5

188

446

N06AX18

ATC

reboxetine; oral

3.1

58.4

256

742

N05AX15

ATC

cariprazine; oral

6.3

58.1

102

144

WX110, ,

SPAT

1.7

58.0

1069

5593

L08

ICPC

Shoulder symptom/complaint

1.3

57.9

4944

34962

F45.0

ICD-10 Finland

Somatization disorder

5.3

57.9

122

206

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

3.8

57.9

182

425

L05

ICPC

Flank/axilla symptom/complaint

1.6

57.9

1355

7545

M02AA10

ATC

ketoprofen; topical

1.4

57.8

3415

22871

M01AH01

ATC

celecoxib; oral

1.3

57.6

3850

26280

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

57.4

705

3254

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

57.4

1455

8260

207

Kela drug reimbursment

Chronic arrhythmias

1.3

57.4

3906

26737

C10AA04

ATC

fluvastatin; oral

1.5

57.3

1990

12106

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

57.3

634

2822

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.0

57.2

684

3129

M03BX02

ATC

tizanidine; oral

1.2

57.0

13202

104848

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

57.0

1209

6566

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.2

57.0

502

2048

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.0

56.9

651

2932

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.2

56.8

231

640

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

56.7

719

3354

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

56.7

940

4771

M54.8

ICD-10 Finland

Other dorsalgia

1.8

56.6

928

4693

RS221, ,

NOMESCO Finland

2.7

56.6

317

1051

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.7

56.4

183

437

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

6.8

56.4

120

R03AC03

ATC

terbutaline; inhalant

1.4

56.4

2743

17780

K30

ICD-10 Finland

Functional dyspepsia

1.5

56.3

2245

14035

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.1

56.3

248

721

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.3

56.3

449

1758

H26.4

ICD-10 Finland

After-cataract

1.4

56.2

2449

15563

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.1

56.2

580

2516

N05AE04

ATC

ziprasidone; systemic

4.6

56.1

138

267

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.9

56.0

281

879

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

4.4

56.0

144

289

L86

ICPC

Back syndrome with radiating pain

1.6

55.9

1307

7275

L29

ICPC

Musculoskeletal sympt/complt other

1.5

55.9

1893

11456

AA1CG, ,

SPAT

3.0

55.8

249

729

G91.0

ICD-10 Finland

Communicating hydrocephalus

4.3

55.7

147

301

C09CA01

ATC

losartan; oral

1.3

55.7

5949

43291

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

6.6

55.5

125

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

3.0

55.5

251

741

L84

ICPC

Back syndrome without radiat pain

1.7

55.4

973

5020

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

55.4

4284

29859

M03BX01

ATC

baclofen; systemic

2.4

55.3

388

1435

L14

ICPC

Leg/thigh symptom/complaint

1.5

55.3

1785

10695

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

55.3

2140

13300

IEY01

NOMESCO Finland

Psychoeducation, individual

4.4

55.3

144

292

S06.2

ICD-10 Finland

Diffuse brain injury

3.1

55.2

238

683

IGP01

NOMESCO Finland

Psychiatric family contact

4.4

55.2

142

285

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

55.1

450

1780

A10BA02

ATC

metformin; oral

1.3

55.0

6690

49443

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

55.0

1523

8824

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

54.7

2038

12569

G03CA04

ATC

estriol; systemic, vaginal

1.6

54.7

1452

8332

L76

ICPC

Fracture: other

1.9

54.6

721

3410

N87

ICPC

Parkinsonism

2.4

54.5

396

1489

A10AE05

ATC

insulin detemir; parenteral

1.7

54.4

1096

5872

WX720

NOMESCO Finland

Own respiration

1.7

54.4

1045

5528

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

54.3

704

3310

T90

ICPC

Diabetes non-insulin dependent

1.3

53.9

5692

41331

M54

ICD-10 Finland

Dorsalgia

1.4

53.9

2368

15067

K78

ICPC

Atrial fibrillation/flutter

1.5

53.9

1878

11430

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

53.7

1468

8479

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

53.3

747

3601

N06AX17

ATC

milnacipran; oral

3.1

53.3

229

656

N05AC02

ATC

thioridazine; oral

2.4

53.3

386

1449

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

5.3

53.3

112

189

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.9

53.2

121

219

WYA30, ,

SPAT

3.7

53.2

173

414

UJH02

NOMESCO Finland

Anoscopy

1.8

53.2

846

4241

H29

ICPC

Ear symptom/complaint other

1.4

53.1

2640

17165

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

53.0

739

3557

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

52.9

1404

8055

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.3

52.8

425

1671

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

9.6

52.5

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

4.1

52.5

150

327

N07

ICPC

Convulsion/seizure

6.0

52.3

142

F44.5

ICD-10 Finland

Dissociative convulsions

68.9

52.0

H57.1

ICD-10 Finland

Ocular pain

1.9

51.9

713

3416

K07.60

ICD-10 Finland

Snapping jaw

1.8

51.8

843

4254

H91.1

ICD-10 Finland

Presbycusis

1.5

51.8

1633

9731

A07AA02

ATC

nystatin; oral

1.6

51.8

1263

7101

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.3

51.8

138

285

I50.0

ICD-10 Finland

Congestive heart failure

1.5

51.7

1903

11703

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

51.7

373

1398

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.9

51.6

256

796

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.4

51.6

194

512

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

5.1

51.5

112

195

N05CD02

ATC

nitrazepam; oral

2.3

51.5

400

1549

Z01.2

ICD-10 Finland

Dental examination

1.2

51.3

9587

74166

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.0

51.2

149

329

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

51.2

637

2953

WYA20, ,

SPAT

3.1

51.2

221

635

C03DA01

ATC

spironolactone; oral

1.4

51.2

2897

19241

R4120, ,

SPAT

2.6

51.1

316

1102

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

51.1

1845

11305

A02BA04

ATC

nizatidine; systemic

1.5

51.0

1632

9754

R1260

NOMESCO Finland

Evaluation of communicative skills

2.4

51.0

367

1374

E000001, ,

ATC

1.3

50.9

3955

27547

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.4

50.8

132

267

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1.9

50.8

698

3343

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.3

50.8

199

539

J20

ICD-10 Finland

Acute bronchitis

1.4

50.7

2081

13067

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

50.7

2093

13157

H13

ICPC

Plugged feeling ear

1.3

50.7

4452

31531

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.1

50.7

509

2186

R96

ICPC

Asthma

1.5

50.5

2037

12750

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.3

50.4

200

546

SPAT1104

SPAT

Monitoring of emergency patient

1.6

50.3

1350

7761

M01AH02

ATC

rofecoxib; oral

1.4

50.3

2732

18019

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

50.3

928

4854

F44.0

ICD-10 Finland

Dissociative amnesia

15.4

50.3

K03.66

ICD-10 Finland

Tooth plaque

1.5

50.1

1590

9485

R51.81

ICD-10 Finland

Facial pain NOS

2.2

50.0

453

1870

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

49.9

844

4307

G04BD11

ATC

fesoterodine; oral

1.9

49.9

647

3041

W06

ICD-10 Finland

Fall involving bed

3.0

49.9

232

696

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

5.9

49.8

140

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

49.8

864

4442

S22

ICPC

Nail symptom/complaint

1.5

49.8

1445

8456

H02AB07

ATC

prednisone; oral

1.4

49.6

2894

19305

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

6.8

49.6

106

N05AF05

ATC

zuclopenthixol; systemic

3.1

49.5

213

611

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

49.5

970

5159

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.9

49.4

149

338

R04.0

ICD-10 Finland

Epistaxis

1.5

49.4

1707

10364

R03BA01

ATC

beclometasone; inhalant

1.4

49.3

2861

19069

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

49.3

1126

6229

M05BA04

ATC

alendronic acid; oral

1.5

49.3

1940

12086

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

9.2

49.2

N06AA04

ATC

clomipramine; systemic

2.4

49.1

345

1278

IEV99

NOMESCO Finland

Other psychiatric network intervention

5.2

49.0

104

177

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.0

48.8

108

191

G43.8

ICD-10 Finland

Other migraine

2.8

48.6

253

808

M01AB55

ATC

diclofenac, combinations; oral

1.5

48.6

1418

8308

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

48.5

591

2721

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.0

48.5

551

2476

C09CA06

ATC

candesartan; oral

1.3

48.4

5148

37338

P73

ICPC

Affective psychosis

4.8

48.4

114

213

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

48.3

1027

5578

R06.5

ICD-10 Finland

Mouth breathing

1.5

48.3

1728

10563

R03DC03

ATC

montelukast; oral

1.3

48.3

3104

21017

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

48.2

1806

11140

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

48.2

1527

9104

OAA80, ,

SPAT

0.5

48.2

558

9188

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.9

48.2

656

3134

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

5.8

48.1

139

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

48.0

5379

39257

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.0

48.0

224

674

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

47.9

1591

9579

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

4.5

47.9

122

243

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.4

47.9

329

1206

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.1

47.9

442

1838

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.9

47.8

233

718

E51.2

ICD-10 Finland

Wernicke encephalopathy

9.9

47.8

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

47.8

6302

46870

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.0

47.7

214

629

N05AA01

ATC

chlorpromazine; systemic, rectal

2.7

47.7

268

891

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

6.0

47.7

128

R30.0

ICD-10 Finland

Dysuria

1.7

47.7

842

4351

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

47.7

1228

6993

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

884

1876

4.28

319.56

3.9

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6345

35014

1.80

318.19

3.2

3.5

0.81

0.82

mmol/l

0.61

5858

32868

(36304419) Bacteria [Presence] in Urine

9131

55885

1.68

315.88

3.9

3.3

23.26

187.89

estimate

0.56

303

(3006315) Basophils [#/volume] in Blood

14772

102220

1.64

313.83

6.7

6.3

0.04

e9/l

2.82

12462

87115

(3030467) Casts [#/volume] in Urine by Automated count

9558

59332

1.67

312.38

4.0

3.3

0.46

e6/l

0.02

7007

43819

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6128

33637

1.80

311.89

3.7

3.2

3.31

2.50

e6/l

4.91

2957

16533

(3001604) Monocytes [#/volume] in Blood

14720

101862

1.63

311.80

6.6

6.3

0.60

e9/l

0.58

12428

86785

(3019977) pH of Arterial blood

4971

25631

1.88

309.14

7.0

7.7

7.42

1.95

2864

13860

(3023368) Bacteria identified in Blood by Culture

10589

60266

1.93

307.65

5.0

4.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

12942

58783

2.86

307.65

1.9

1.7

20.32

20.15

nmol/l

0.59

11499

49146

(3023183) Ammonium ion [Moles/volume] in Plasma

1677

4096

3.81

307.65

2.8

2.5

30.77

34.38

umol/l

6.46

1457

3701

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12459

78106

1.78

307.65

5.1

3.8

54.50

81.33

ng/l

1.23

9311

57445

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

21182

154117

2.10

307.65

9.0

8.5

79.51

81.19

u/l

4.62

20245

145954

(3015377) Calcium [Moles/volume] in Serum or Plasma

13056

70548

2.26

307.65

3.1

3.6

2.35

mmol/l

2.03

11841

63738

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1661

603

25.98

307.65

1.0

40.45

43.14

ng/l

0.62

1390

322

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7844

39149

2.10

307.65

4.9

3.8

212.53

535.49

ng/l

12.79

6506

31950

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10377

64821

1.69

307.65

3.0

2.7

117.06

65.64

u/l

0.42

9649

59884

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7392

35281

2.19

307.65

2.2

1.9

—

(3018095) Leukocytes [#/volume] in Urine

12031

76941

1.71

307.65

5.1

4.0

101.60

117.80

e6/l

0.97

8599

54734

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9726

54872

1.90

307.65

2.6

2.4

2.71

2.93

mg/l

15.78

8382

47087

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4264

19706

2.09

307.65

2.2

1.7

1.60

1.49

16.46

3729

17035

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14504

89336

1.97

307.65

2.7

2.4

77.06

1104.51

nmol/l

0.50

13174

79928

(3002582) Erythrocytes [#/volume] in Urine

11007

68536

1.72

307.65

4.2

3.4

68.30

103.56

e6/l

2.52

8414

52455

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1643

607

25.51

307.65

1.0

329.35

353.49

ng/l

0.41

1397

332

(3013650) Neutrophils [#/volume] in Blood by Automated count

16229

114257

1.67

307.65

10.1

9.8

4.34

4.22

e9/l

6.40

13845

98614

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5583

24278

2.32

307.65

2.1

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1657

601

25.99

307.65

1.0

778.53

695.34

ng/l

3.59

1361

316

(3032080) INR in Blood by Coagulation assay

15489

98221

1.96

307.65

19.3

16.2

1.32

1.29

inr

5.65

13194

82090

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

20408

146741

2.02

307.65

5.1

4.3

14.84

14.92

pmol/l

4.03

18884

133361

(3015736) pH of Urine

12760

84542

1.65

307.65

4.4

3.5

6.31

6.23

11.50

6403

46701

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5949

25986

2.33

307.65

2.1

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2463

3072

7.73

307.65

1.2

1.3

3.81

3.78

mmol/l

0.49

2336

2913

(3031040) Bacteria [#/volume] in Urine by Automated count

19671

131241

2.28

307.65

6.7

4.7

2168.41

1583.53

e6/l

0.74

414

1934

(3037467) Urinalysis macro (dipstick) panel - Urine

19394

135804

2.00

307.65

6.0

4.6

2.57

65.58

0.49

210

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

22939

176009

2.17

307.65

6.8

5.2

1.93

1.97

mu/l

1.63

21534

161129

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2695

3497

7.49

307.65

1.3

1.4

510.53

583.41

mg/l

3.41

2553

3365

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12933

61311

2.70

307.65

2.8

2.1

251.11

213.08

u/l

2.29

12400

57424

(3009466) Valproate [Moles/volume] in Serum or Plasma

1328

2054

5.98

307.65

5.4

4.9

354.88

354.09

umol/l

0.06

1158

1766

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

16797

91195

2.73

307.65

2.7

2.1

94.82

95.48

pmol/l

1.00

9324

48116

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

708

1158

5.54

307.65

1.2

1.3

2.10

2.24

mmol/l

1.47

665

1065

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8727

40862

2.33

307.65

3.0

3.1

2.45

2.46

mmol/l

7.51

7837

36495

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16849

93665

2.64

307.65

6.8

1.21

mmol/l

0.19

15818

86173

(3018418) pH of Serum or Plasma

12197

62388

2.36

307.65

4.0

4.5

7.40

6.46

8909

44724

(3033658) Prothrombin time (PT) actual/Normal

8768

51524

1.76

307.65

4.8

4.2

86.31

87.84

6.37

8548

50425

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6885

30437

2.36

307.65

2.0

2.1

29.34

29.86

9.22

6707

29580

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

768

1316

5.30

307.65

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2381

3020

7.58

307.65

1.3

1.4

21.34

37.16

e6/l

1.08

1657

2303

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

898

1513

5.41

307.65

1.4

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

16119

108238

1.82

307.65

6.4

6.8

11.57

11.92

umol/l

2.70

15362

103135

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

523

620

7.60

307.65

1.2

1.3

58.20

62.37

0.27

(3024561) Albumin [Mass/volume] in Serum or Plasma

16330

93668

2.43

307.65

5.2

35.31

35.16

g/l

2.80

15245

87472

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2419

3052

7.63

307.65

1.3

1.5

2657.79

2164.38

e6/l

0.10

1805

2477

(3023410) Appearance of Cerebral spinal fluid

1194

1283

8.59

307.65

1.4

1.6

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

20067

145185

1.93

307.65

5.0

4.5

13.19

13.22

mm/h

0.07

18779

134942

(3013826) Glucose [Moles/volume] in Serum or Plasma

18397

118980

2.22

307.65

6.3

5.1

6.73

6.80

mmol/l

4.57

17681

113022

(3019309) Folate [Moles/volume] in Red Blood Cells

8978

35579

2.87

307.65

1.8

1127.84

1162.23

nmol/l

2.76

6822

26668

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18130

104880

2.69

307.65

7.7

7.4

1.21

mmol/l

3.37

16201

89584

(3013115) Eosinophils [#/volume] in Blood

15071

105118

1.63

307.06

7.1

6.5

0.19

e9/l

2.26

12852

90996

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13331

90310

1.62

305.06

3.5

3.1

123.11

144.09

ug/l

21.13

12337

83422

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

23883

189838

2.19

303.50

25.0

16.9

25.19

26.50

mg/l

8.41

20974

158013

(3019198) Lymphocytes [#/volume] in Blood

14927

104086

1.62

302.29

6.7

6.4

1.87

1.90

e9/l

0.70

12794

90896

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7424

43395

1.72

301.66

1.8

1.7

21440401.04

30634019.28

pmol/l

0.89

6278

35386

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6520

36757

1.76

301.31

3.5

3.0

1.15

1.21

e6/l

0.24

3391

19710

(3003396) Base excess in Arterial blood by calculation

4918

25476

1.87

300.48

6.9

7.6

1.19

0.91

mmol/l

4.89

4033

21128

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4944

25666

1.87

299.98

6.9

7.7

5.05

5.09

kpa

2.17

4721

24691

(3027801) Oxygen [Partial pressure] in Arterial blood

4940

25652

1.87

299.42

6.9

7.6

12.08

12.25

kpa

1.30

4716

24669

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

545

812

6.05

293.87

1.2

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2022

7497

2.50

291.43

2.2

2.3

512.91

616.16

ug/l

0.71

1914

7120

(3035350) Ketones [Presence] in Urine by Test strip

15166

106768

1.61

289.37

5.0

4.0

4.38

4.05

estimate

0.08

2713

23340

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4287

21491

1.92

288.47

3.8

3.9

5.87

5.81

kpa

2.99

4160

20992

(3009261) Glucose [Presence] in Urine by Test strip

15223

107627

1.60

281.79

5.0

4.0

0.56

0.36

estimate

0.20

2536

21961

(3014111) Lactate [Moles/volume] in Serum or Plasma

3941

19410

1.94

278.72

6.1

7.7

1.39

1.36

mmol/l

0.99

3845

19013

(3021601) Nitrite [Presence] in Urine by Test strip

14948

105454

1.59

277.09

5.0

3.9

0.00

estimate

0.14

2659

22688

(3002032) Base excess in Venous blood by calculation

4158

20889

1.91

276.92

3.8

3.9

1.83

1.76

mmol/l

0.53

3671

18237

(3012544) pH of Venous blood

4297

21858

1.89

275.30

3.8

4.0

7.38

0.08

2414

12826

(3019069) Monocytes/Leukocytes in Blood

13633

94318

1.58

273.13

6.8

6.7

8.92

8.98

1.69

12768

88169

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3650

17626

1.97

273.00

2.1

2.4

389.33

381.41

nmol/l

1.12

3337

16366

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

489

709

6.21

270.77

1.2

1.1

—

(3006504) Eosinophils/Leukocytes in Blood

13574

94063

1.57

267.89

6.8

6.6

2.78

2.84

2.49

12708

87897

(40758558) Short blood count panel - Blood

9454

60279

1.61

266.17

6.7

6.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

24285

196049

2.20

264.55

30.3

20.1

139.51

139.66

mmol/l

14.03

23987

191926

(3022096) Basophils/Leukocytes in Blood

13546

94127

1.56

261.55

6.8

6.6

0.65

0.67

3.84

12681

87943

(3011397) Hemoglobin [Presence] in Urine by Test strip

7933

48666

1.63

260.09

4.7

3.8

0.29

0.25

0.10

565

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3486

16857

1.96

258.65

3.3

3.0

217.81

227.15

ng/l

0.47

3198

15494

(3023103) Potassium [Moles/volume] in Serum or Plasma

24288

196398

2.18

257.58

30.4

20.3

3.98

3.99

mmol/l

5.76

23966

191989

(3018010) Neutrophils/Leukocytes in Blood

13518

94220

1.56

254.70

6.7

6.4

58.49

57.92

6.43

12842

89789

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1851

7000

2.44

254.64

1.9

1.6

0.32

0.31

mg/l

0.30

882

3357

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17002

124817

1.58

254.32

4.3

3.3

53.17

52.14

u/l

0.58

15981

116125

(3002030) Lymphocytes/Leukocytes in Blood

13742

96237

1.55

252.59

6.8

6.6

26.23

26.96

11.63

12995

90981

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2713

12088

2.10

252.09

3.6

4.2

24.28

24.12

mmol/l

1.78

2649

11949

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4106

21131

1.85

251.48

7.6

8.5

120.99

120.53

g/l

0.74

4012

20655

(3019150) Specific gravity of Urine by Refractometry

7536

46153

1.62

245.87

5.4

4.2

1.02

1.15

kg/l

1.33

5268

30712

(3044889) 12 lead EKG panel

18388

137992

1.59

245.00

5.1

4.2

0.38

2580.61

1.18

296

(3024354) Oxygen [Partial pressure] in Venous blood

3582

17814

1.90

243.35

3.3

3.2

4.48

4.50

kpa

0.24

3455

17355

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10151

66870

1.56

241.89

3.4

3.2

1657.85

1583.54

ng/l

0.71

8772

58006

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3519

17481

1.90

239.61

2.7

2.3

5.94

7.61

ug/l

5.09

2917

15301

(3000991) Gas panel - Venous blood

3696

18656

1.88

239.58

7.0

9.1

—

(3016502) Oxygen saturation in Arterial blood

4311

22937

1.79

235.34

7.1

8.0

95.54

95.37

0.91

4148

22160

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2713

12419

2.04

233.52

2.5

2.4

23.23

22.99

au/ml

0.04

178

1284

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9880

65231

1.55

229.60

3.6

3.3

35.07

34.71

u/l

0.10

9257

61339

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2527

11342

2.08

229.20

1.3

49.36

56.98

au/ml

0.77

105

763

(3000850) Epithelial cells [#/volume] in Urine

7628

47541

1.59

227.89

3.1

2.8

5.50

5.22

e6/l

0.99

6946

43293

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5053

28607

1.70

219.89

5.3

6.1

1.03

1.04

mmol/l

2.48

4635

26581

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

550

1077

4.60

219.46

1.2

1.1

44.48

45.43

mg/l

0.08

467

908

(3022948) Iron [Moles/volume] in Serum or Plasma

6214

37477

1.61

209.74

2.6

2.7

11.89

12.66

umol/l

14.32

5738

34720

(3026782) Osmolality of Urine

6627

40594

1.60

209.63

3.3

3.0

520.80

534.08

mosm/kgh2o

5.63

5784

35629

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

407

635

5.75

209.35

2.4

2.3

53.73

52.22

umol/l

0.36

350

550

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2787

13364

1.95

209.03

7.5

6.8

24.62

24.53

mmol/l

0.54

2681

12795

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3121

15555

1.88

208.29

1.8

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3613

18896

1.80

206.43

2.7

2.5

40.42

49.53

u/l

0.56

3020

15997

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6827

42240

1.58

206.37

2.0

1.7

1.35

1.40

mg/l

0.56

5367

33297

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

523

1034

4.55

206.23

1.1

292.95

294.83

mg/l

0.03

468

914

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5857

35168

1.61

199.80

2.6

2.27

2.29

g/l

2.95

5378

32374

(3024666) Lithium [Moles/volume] in Serum or Plasma

421

727

5.20

194.33

15.7

13.2

0.63

0.62

mmol/l

0.16

390

656

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

436

779

5.03

193.71

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

426

751

5.09

192.15

1.3

0.53

0.69

ratio

1.12

262

419

(3020191) Ethanol [Moles/volume] in Serum or Plasma

586

1341

3.94

191.10

1.8

1.3

0.93

1.28

promille

5.63

457

1048

(3027945) Reticulocytes/Erythrocytes in Blood

4589

26230

1.67

189.20

2.4

2.5

1.78

0.04

3996

23252

(1001926) Buprenorphine [Presence] in Urine by Screen method

1078

3664

2.68

183.70

3.7

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

307

413

6.65

182.46

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

8319

54922

1.50

182.03

3.5

3.0

0.12

0.07

0.62

139

1593

(3011288) Drugs identified in Urine by Screen method Nominal

986

3220

2.78

181.44

4.7

2.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

473

971

4.38

177.95

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5387

32662

1.58

172.66

2.7

21.06

22.25

8.55

4949

30224

(4198724) Urine methamphetamine measurement

315

468

6.02

170.23

3.4

2.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3061

16298

1.75

161.57

3.5

4.0

89.27

93.88

ng/l

2.03

2630

13955

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6500

41588

1.51

161.48

1.4

1.3

1.74

1.72

u/ml

0.02

1494

10891

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

22679

184263

1.64

161.33

6.1

5.4

6.06

6.00

mmol/l

7.32

20932

167914

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

297

441

6.02

160.60

1.2

17.26

23.97

0.45

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4081

23527

1.63

159.82

2.7

2.8

8.49

9.44

umol/l

1.79

3492

20676

(40761511) CBC panel - Blood by Automated count

23586

193755

1.73

158.72

21.8

15.1

—

106.99

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

24379

202334

1.87

156.61

31.9

22.3

81.22

80.24

umol/l

3.43

24143

199598

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

380

740

4.60

152.60

21.9

19.1

1357.41

2691.25

nmol/l

0.52

365

709

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

371

716

4.64

150.61

1.1

—

0.77

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

377

745

4.53

148.71

2.3

2.0

123.52

116.83

umol/l

0.15

188

368

(3016879) Cocaine [Presence] in Urine

1153

4471

2.34

148.25

3.7

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1092

4137

2.40

147.95

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1092

4137

2.40

147.95

1.4

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

22241

180724

1.57

147.04

7.6

6.7

40.18

39.71

mmol/mol

10.59

20765

167664

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

360

699

4.61

145.09

16.2

14.1

796.14

2680.09

nmol/l

0.51

344

672

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

367

742

4.43

140.74

1.1

1.13

1.14

u/l

0.09

138

328

(3047181) Lactate [Moles/volume] in Blood

1419

6132

2.11

139.94

6.2

5.8

1.35

1.33

mmol/l

0.30

1261

5429

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

334

629

4.75

139.62

1.1

280.32

714.56

ng/l

0.95

193

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

19496

154867

1.44

137.03

33.3

21.7

331.28

331.85

g/l

15.05

19372

153907

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2412

12540

1.77

136.94

8.7

10.0

16.00

15.95

0.38

2321

12116

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1454

6413

2.07

135.74

1.3

—

(3003181) Sodium [Moles/volume] in Urine

1012

3855

2.38

135.30

1.5

1.4

60.77

61.01

mmol/l

0.06

811

3064

(3000764) Benzodiazepines [Presence] in Urine

1177

4805

2.22

133.86

3.7

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24035

200052

1.71

131.24

15.1

12.5

25.31

25.99

u/l

3.35

23442

193502

(3028300) Cannabinoids [Presence] in Urine

1178

4851

2.21

131.11

3.8

1.9

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

245

368

5.94

131.01

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

1176

4841

2.21

131.01

3.5

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

247

377

5.85

129.97

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

4004

24219

1.55

124.77

2.0

1.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2143

11131

1.77

121.39

3.1

2.9

1.30

1.22

3.25

2134

11078

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

286

540

4.73

119.23

2.8

3.1

28.65

28.29

umol/l

0.18

205

411

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

19491

156118

1.40

118.93

30.8

20.8

13.84

13.75

18.94

19324

153892

(1761868) Lipid panel - Serum or Plasma

6085

69983

0.70

118.89

3.4

3.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2554

14013

1.68

118.60

8.3

9.9

0.66

0.63

3.16

2540

13927

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2115

11026

1.76

118.16

3.1

2.9

0.63

0.62

0.40

2107

10990

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3481

20700

1.56

116.26

2.3

0.20

0.21

g/l

2.33

3172

19275

(3027944) Amphetamines [Presence] in Urine

1122

4772

2.13

114.91

3.8

1.8

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2605

14497

1.66

114.33

8.1

9.6

1.37

1.32

1.65

2590

14402

(3020779) Urea [Moles/volume] in Serum or Plasma

3375

20038

1.56

113.26

6.6

7.4

9.77

10.75

mmol/l

12.44

3211

19073

(36660697) Celiac disease serology panel - Serum

2598

14494

1.65

112.84

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

3435

20518

1.56

112.14

2.4

2.6

68.75

68.57

e9/l

0.09

2427

15322

(3007461) Platelets [#/volume] in Blood

24445

205533

1.72

112.08

37.4

25.7

243.96

247.82

e9/l

16.11

24025

200611

(3035941) MCH [Entitic mass]

24447

205574

1.71

111.74

37.2

25.5

30.42

30.37

3.82

24224

202943

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

24448

205589

1.71

111.67

38.0

26.1

39.49

40.47

23.87

24220

202869

(3010813) Leukocytes [#/volume] in Blood

24451

205622

1.72

111.65

37.4

25.7

6.94

6.81

e9/l

10.44

23978

199865

(3024731) MCV [Entitic mean volume] in Red Blood Cells

24447

205585

1.71

111.56

37.3

25.6

91.65

91.39

15.42

24230

202950

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

178

226

7.02

111.56

2.0

16.02

17.07

umol/l

0.49

178

226

(3026361) Erythrocytes [#/volume] in Blood

24447

205599

1.71

111.32

37.3

25.6

4.36

4.46

e12/l

148.93

23966

199813

(3020630) Protein [Mass/volume] in Serum or Plasma

3227

19034

1.57

111.30

2.3

2.8

65.93

66.19

g/l

1.10

2878

17413

(3000963) Hemoglobin [Mass/volume] in Blood

24447

205626

1.71

110.86

37.7

25.8

131.49

134.37

g/l

167.66

24227

203036

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

236

403

5.23

110.36

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

12586

94885

1.33

108.68

3.0

2.8

—

estimate

—

(3039000) Anion gap in Blood by calculation

1013

4236

2.16

108.25

7.0

6.9

11.14

11.27

mmol/l

0.57

924

3812

(3018572) Chloride [Moles/volume] in Blood

1013

4237

2.16

108.18

7.0

6.9

104.88

105.01

mmol/l

0.35

924

3814

(3004119) Hemoglobin [Mass/volume] in Venous blood

2400

13278

1.66

107.39

3.4

3.3

128.45

128.10

g/l

0.33

2335

12894

(3024928) Oxygen saturation in Venous blood

1163

5162

2.04

106.25

2.6

3.3

60.75

61.31

0.35

1074

5001

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7282

50744

1.37

104.46

2.7

2.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2402

13392

1.65

104.14

7.7

9.5

24.48

24.22

mmol/l

3.44

2306

13075

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

255

495

4.60

102.88

2.3

2.6

142.07

144.80

nmol/l

0.13

224

439

(3014007) Fractional oxyhemoglobin in Arterial blood

2557

14533

1.62

102.56

8.3

9.7

93.78

93.81

0.07

2552

14486

(3042936) Bacteria identified in Isolate by Culture

4676

30380

1.44

99.96

2.2

2.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1853

9743

1.74

99.83

5.8

4.9

1.71

1.60

3.10

1755

9245

(3007164) IgA [Mass/volume] in Serum or Plasma

5479

36701

1.41

98.58

1.5

2.55

2.54

g/l

0.21

2982

22314

(3007930) Methemoglobin/Hemoglobin.total in Blood

1717

8879

1.76

97.99

6.0

5.1

0.90

0.87

2.00

1622

8396

(3036489) Thrombin time

1428

7018

1.85

96.45

1.9

2.0

21.10

21.41

0.84

1272

6266

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2459

14255

1.58

90.17

6.8

8.1

24.95

24.72

mmol/l

2.32

2439

14150

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1704

9088

1.71

86.81

1.1

1.20

4.31

u/ml

0.83

116

(3020891) Body temperature

1842

10068

1.67

85.55

5.3

4.4

36.92

36.90

°c

1.57

1825

9959

(3043409) Potassium [Moles/volume] in Arterial blood

1189

5724

1.88

85.50

4.7

4.3

3.87

3.90

mmol/l

1.08

1182

5669

(3008295) Osmolality of Serum or Plasma

577

2108

2.46

84.36

1.4

277.26

277.28

mosm/kgh2o

0.01

417

1623

(3018405) Lactate [Moles/volume] in Arterial blood

1368

6924

1.79

83.67

4.4

4.0

1.45

1.39

mmol/l

0.94

1350

6781

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2051

11605

1.61

82.94

3.0

3.5

4.33

4.44

pmol/l

5.62

1780

10398

(3014765) Yersinia sp identified in Stool by Organism specific culture

1057

4972

1.92

81.51

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1918

10724

1.63

81.35

1.7

1.55

1.57

g/l

0.24

1617

9166

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10548

79637

1.29

80.68

5.2

4.0

0.97

0.61

estimate

0.34

2113

18562

(42529406) Shigella sp [Presence] in Stool by Culture

1054

4981

1.91

80.14

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1047

4938

1.91

80.09

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

1162

5670

1.85

80.02

3.8

3.4

2.30

2.03

index

0.70

626

2800

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

532

1924

2.48

79.49

1.4

1.9

14109.09

2026.34

titre

0.67

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2841

17469

1.49

78.92

3.0

2.5

0.38

0.46

e6/l

1.38

2736

16750

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1609

8673

1.69

78.58

2.2

2.5

2.90

2.93

g/l

0.54

1405

7804

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1498

7953

1.71

77.37

2.2

2.4

10.06

10.26

g/l

0.89

1275

7010

(3048689) Calprotectin [Mass/mass] in Stool

3597

23312

1.42

75.66

2.1

2.3

136.49

145.09

ug/g

0.65

2840

18387

(3042517) Benzodiazepines panel - Urine

101

106

8.47

74.18

3.9

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

22683

190293

1.40

73.10

6.6

6.0

2.50

2.65

mmol/l

130.22

21096

175659

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1663

9234

1.64

72.24

2.2

2.4

3.72

3.76

g/l

0.43

1460

8373

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1664

9253

1.63

71.85

2.2

2.4

4.14

4.21

g/l

2.57

1459

8396

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1666

9267

1.63

71.85

2.2

2.4

7.36

7.44

g/l

1.24

1463

8397

(3029937) Albumin [Presence] in Urine by Test strip

8157

60222

1.29

71.85

5.5

4.1

0.00

estimate

0.26

2444

20519

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

139

217

5.70

71.63

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1277

6625

1.74

71.54

2.1

2.5

0.03

g/l

0.30

1128

5927

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1171

5942

1.78

70.81

2.2

2.6

0.00

g/l

-0.00

1059

5545

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1470

7949

1.68

70.75

2.3

2.6

0.86

0.98

g/l

0.60

1244

6737

(40768797) Stomach Pathology biopsy report

4159

27934

1.38

70.49

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4161

27957

1.38

70.36

1.9

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3975

26538

1.39

69.82

3.5

4.5

241.40

246.21

u/l

1.00

3697

25188

(3005719) IgG [Mass/volume] in Serum or Plasma

2495

15305

1.49

69.60

2.6

3.0

10.69

10.65

g/l

0.16

2255

14144

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1882

10876

1.57

69.15

4.5

4.0

49.92

46.55

7.54

1868

10720

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

126

186

6.03

68.70

1.2

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2391

14601

1.50

68.12

3.9

3.8

5.19

5.14

kpa

1.61

2261

13886

(3000494) Fungus identified in Specimen by Culture

3655

24159

1.40

67.99

1.6

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

119

169

6.26

67.38

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1222

6371

1.73

67.21

2.1

2.5

0.00

g/l

0.02

1061

5557

(21494755) Public health laboratory ask at order entry panel

870

13759

0.55

66.22

1.3

1.4

—

(3009343) pH of Capillary blood

2320

14181

1.49

65.66

3.9

3.8

7.42

0.67

1955

11848

(3009508) Creatinine [Moles/volume] in Urine

9750

74190

1.26

65.34

3.6

3.5

7.21

7.40

mmol/l

3.92

8340

62026

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2070

12384

1.52

64.92

3.7

3.6

1.86

1.87

mmol/l

0.06

1522

9130

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

232

592

3.49

64.81

2.9

2.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

126

200

5.60

63.86

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

306

944

2.89

62.51

2.4

2.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

21889

183589

1.33

61.65

23.4

16.9

76.85

77.74

ml/min/173m2

8.20

20674

170000

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1182

6301

1.69

59.86

1.5

1.4

269.89

261.30

ug/g

0.71

675

3719

(3027273) Bicarbonate [Moles/volume] in Venous blood

1694

9874

1.56

59.66

3.9

3.4

25.27

25.22

mmol/l

0.26

1632

9572

(3016038) Potassium [Moles/volume] in Urine

381

1355

2.51

59.06

1.4

1.2

33.28

35.00

mmol/l

0.79

328

1172

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

314

1021

2.75

58.22

1.1

4.50

8.28

nmol/l

0.77

209

(3037522) Nuclear Ab [Titer] in Serum

3893

26685

1.34

56.58

1.4

1.3

477.52

514.48

titre

0.66

818

5919

(3021589) Normoblasts [#/volume] in Blood

11366

89120

1.23

54.51

13.0

12.1

0.00

e9/l

0.28

8931

72661

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3581

24372

1.35

54.36

9.8

7.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

11.05

54.06

1.0

9279.38

11124.00

ng/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

154

5.77

52.34

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1259

17023

0.64

50.84

1.9

2.0

3.38

3.48

ratio

2.09

1013

13357

(3004716) Salmonella sp identified in Stool by Organism specific culture

1360

7871

1.56

49.22

1.3

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

852

12411

0.60

47.20

1.7

3.33

3.46

mmol/l

2.52

608

8692

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1310

7589

1.56

47.18

3.0

0.37

0.35

iu/ml

1.00

745

4192

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1315

7628

1.56

47.08

2.1

1.8

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

126

264

4.24

46.46

1.1

7.94

8.17

mg/g

0.11

120

252

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

109

206

4.70

45.64

3.0

2.9

42.77

39.09

umol/l

0.86

170

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

134

5.77

45.57

1.1

1.0

—

(4024509) Urine culture

1543

9333

1.49

45.41

2.1

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

7297

55393

1.23

45.34

2.7

2.9

344.94

350.26

umol/l

3.92

6235

48457

(3019225) pH of Specimen

3010

20467

1.34

45.31

4.8

4.3

7.37

7.36

6.49

2224

14571

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

196

4.76

44.62

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

129

5.78

44.14

1.1

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1326

7816

1.53

44.10

2.9

3.0

24.78

24.73

mmol/l

0.20

1296

7693

(3019832) Treponema pallidum Ab [Presence] in Serum

1880

11894

1.43

43.78

1.6

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

871

4653

1.68

43.67

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1036

5801

1.61

43.13

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1093

6199

1.59

43.12

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

22068

187124

1.27

43.09

5.6

5.3

4.40

4.57

mmol/l

116.26

20491

173446

(3027456) Digoxin [Moles/volume] in Serum or Plasma

886

4774

1.67

42.99

3.7

3.2

0.77

0.81

nmol/l

2.64

725

3792

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2388

15823

1.37

42.34

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

107

213

4.46

42.11

1.2

63.58

62.84

ug/l

0.11

107

213

(44790049) Parainfluenza type 3 nucleic acid detection

547

2587

1.89

41.47

1.4

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

547

2587

1.89

41.47

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

547

2587

1.89

41.47

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

547

2587

1.89

41.47

1.4

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4760

34763

1.26

41.33

1.4

1.3

39.03

37.42

iu/ml

0.08

1376

10848

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

12.31

40.67

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

299

1138

2.34

40.14

1.9

—

(3025941) Bacteria identified in Stool by Culture

1599

9986

1.45

39.84

1.3

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2892

19918

1.32

39.49

1.7

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

132

325

3.61

39.09

2.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1021

5834

1.57

38.99

1.8

1.6

0.23

0.24

g/l

0.97

949

5566

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1043

5990

1.57

38.96

1.8

1.6

1.18

1.19

g/l

0.61

976

5742

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

461

2105

1.96

38.83

1.5

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

21875

185817

1.25

38.33

5.4

5.2

1.43

1.46

mmol/l

19.17

20221

171022

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1498

9310

1.45

38.27

2.1

1.9

2.44

2.26

ug/l

0.22

1243

8272

(3021387) Prolactin [Units/volume] in Serum or Plasma

837

4583

1.64

38.15

2.0

1.7

373.69

285.15

mu/l

5.76

752

4191

(3051611) Lipemic interference index of Serum or Plasma

443

2013

1.97

37.85

3.7

3.5

13.24

12.90

index

0.18

273

1064

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

137

354

3.44

37.76

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

518

2482

1.87

37.75

6.2

10.3

7.22

7.49

mmol/l

0.83

424

2073

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

306

1211

2.25

37.54

2.1

2.2

16.99

17.24

nmol/l

0.20

288

1132

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

132

340

3.45

36.58

2.0

1.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1215

7311

1.50

36.56

1.3

1.2

0.53

0.89

u/ml

1.20

108

584

(3028679) Herpes simplex virus Ab [Presence] in Serum

235

841

2.49

36.16

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

20956

177530

1.22

35.49

4.6

4.4

1.30

1.28

mmol/l

3.27

19069

161744

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1350

8346

1.46

35.42

2.3

2.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

165

498

2.95

35.28

1.2

128.72

127.05

nmol/l

0.04

111

354

(3020682) Albumin/Creatinine [Ratio] in Urine

9204

72722

1.19

35.15

4.1

4.2

9.78

8.65

mg/mmol

1.29

5803

45218

(3014271) Vancomycin [Susceptibility]

269

1039

2.31

34.98

3.3

2.9

—

(3049717) Cytology report of Urine Cyto stain

1394

8722

1.44

34.30

2.5

2.9

—

(3013512) EKG study

9213

72943

1.18

34.01

4.2

3.7

0.83

0.75

0.41

187

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

266

4984

0.47

33.95

1.1

0.60

0.63

ratio

0.59

736

(3037756) Immunofixation for Serum or Plasma

869

4946

1.58

33.75

1.5

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

379

1707

1.98

33.28

1.6

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1341

8380

1.44

33.20

1.8

1.9

38.17

39.29

u/l

1.16

1158

7358

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.95

33.07

1.0

—

(3012516) Albumin [Mass/volume] in Urine

9003

71273

1.18

32.98

3.5

54.33

48.18

mg/l

1.09

5848

45519

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1244

7687

1.46

32.69

4.4

4.0

24.93

24.86

mmol/l

0.35

1134

7028

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

992

5885

1.51

31.94

2.2

2.3

93.49

91.10

2.46

944

5667

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1290

8078

1.44

31.57

2.8

3.5

37.89

46.21

mg/l

1.85

1114

6801

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

5.48

31.44

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1291

8093

1.43

31.40

2.8

3.5

48.06

67.67

mg/l

1.79

1113

6811

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

183

625

2.61

31.08

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10124

81221

1.17

30.83

2.0

1.9

1.35

1.34

mmol/l

0.36

8844

66953

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

579

3048

1.70

30.73

5.8

6.3

12.13

12.07

mg/l

0.12

528

2821

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

339

1538

1.97

29.22

1.8

1.7

444.04

349.19

mu/l

1.48

272

1212

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

500

2566

1.74

29.11

1.3

1.2

4.19

3.92

u/ml

0.19

226

1219

(3006184) Hemoglobin [Mass/volume] in Capillary blood

912

5424

1.51

29.03

2.2

2.3

128.81

128.43

g/l

0.17

706

4138

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

774

4445

1.56

28.94

1.2

1.1

4.97

3.66

0.45

538

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1370

8817

1.40

28.69

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1157

7239

1.44

28.43

2.8

3.4

2.71

6.41

ratio

1.39

706

4190

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

913

5460

1.50

28.30

2.4

194.41

201.32

1.42

862

5199

(3041096) Erythrocytes [Presence] in Urine by Automated

7150

56127

1.18

27.79

4.3

3.5

0.57

0.30

estimate

0.54

2050

17903

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

779

4533

1.54

27.47

1.8

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

913

5498

1.49

27.36

1.5

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

203

779

2.32

26.93

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

607

3350

1.62

26.88

2.3

1.8

1.76

1.72

mmol/l

0.42

586

3266

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

926

5626

1.47

26.55

1.5

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

552

2993

1.65

26.24

1.7

1.6

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

209

3.65

26.11

1.6

1.3

41.76

54.30

1.30

101

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1233

7927

1.40

25.96

2.9

2.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

5.92

25.93

1.1

1.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

908

5532

1.47

25.67

3.2

3.3

8.06

8.03

kpa

0.23

884

5404

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

398

1987

1.79

25.54

1.6

1.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

5.55

25.31

1.1

1.0

—

(3017732) Neutrophils [#/volume] in Blood

3435

25412

1.23

25.17

3.5

3.2

4.74

4.65

e9/l

0.22

2840

21721

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

906

5553

1.46

24.85

1.3

—

(3045414) Leukocytes [Presence] in Urine

2770

20050

1.25

24.82

2.3

2.1

0.00

0.01

estimate

6.74

550

3874

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

123

386

2.83

24.68

1.4

1.5

449.70

834.41

mu/l

0.72

115

367

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

124

393

2.80

24.44

1.4

1.5

72.53

73.45

0.28

116

374

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

805

4837

1.49

24.41

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7236

57335

1.16

24.25

5.0

4.7

22.33

22.12

0.53

3405

29761

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

740

4381

1.51

24.11

1.1

5.61

8.01

eliau/ml

0.42

486

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

339

1648

1.83

23.78

1.6

26.15

25.11

u/ml

0.13

329

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4267

32407

1.20

23.74

1.3

11.57

12.84

u/ml

0.31

1413

12289

(3023420) DNA double strand Ab [Units/volume] in Serum

1225

8019

1.37

23.11

1.8

6.83

7.65

iu/ml

0.46

315

1871

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

668

3907

1.53

23.06

2.7

2.2

5933.81

5272.29

u/l

0.16

196

1476

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

5.26

22.99

1.0

1.1

2.35

3.71

u/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1706

11736

1.31

22.99

1.2

110.83

137.71

u/ml

1.41

596

4346

(3028026) IgM [Mass/volume] in Serum or Plasma

1760

12171

1.30

22.81

1.9

2.0

1.41

1.34

g/l

0.60

1586

11142

(3007463) Buprenorphine [Presence] in Urine

7.70

22.59

7.9

6.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.58

22.43

1.6

1.5

521.35

525.18

nmol/l

0.01

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

154

568

2.41

22.42

1.5

14.67

15.57

pmol/l

0.98

122

473

(3024869) Neuronal Ab [Presence] in Serum

106

324

2.91

22.36

1.0

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

271

1252

1.93

22.29

1.3

1.4

13.55

13.32

umol/l

0.17

251

1178

(4195642) Thrombophilia screening test

445

2394

1.66

21.89

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1359

9131

1.34

21.63

1.3

1.6

15.79

16.21

iu/ml

0.02

222

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

477

2632

1.62

21.24

1.3

1.2

5.45

3.68

u/ml

0.88

172

1000

(3009214) Lutropin [Units/volume] in Serum or Plasma

732

4441

1.47

21.19

1.4

10.38

10.92

u/l

0.48

568

3544

(3021901) Oxygen saturation in Capillary blood

778

4777

1.46

21.18

2.7

3.1

89.83

89.43

1.05

751

4659

(3020961) Endomysium IgA Ab [Titer] in Serum

1230

8178

1.35

21.00

1.1

173.38

191.71

titre

0.12

219

(3045424) Erythrocytes [Presence] in Urine

1492

10202

1.31

20.99

2.2

2.1

0.56

0.13

estimate

0.35

454

2972

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1067

6940

1.38

20.96

1.6

22.50

20.96

u/ml

0.21

158

1533

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

289

1393

1.85

20.91

1.3

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1164

7688

1.36

20.76

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

284

1372

1.84

20.41

1.3

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

126

444

2.52

20.27

1.3

1.2

15.99

16.56

umol/l

0.76

105

386

(3005322) IgE [Units/volume] in Serum or Plasma

1658

11553

1.29

20.25

1.4

1.3

224.96

255.27

u/ml

0.45

1546

10715

(40757494) Bilirubin.total [Moles/volume] in Blood

222

995

1.99

19.99

2.0

2.2

25.84

30.67

umol/l

0.20

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

246

1143

1.92

19.95

1.6

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

538

3103

1.55

19.86

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

953

6145

1.39

19.74

2.1

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

290

1435

1.80

19.31

1.1

1.0

287.86

290.82

mg/l

0.26

259

1302

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

161

3.58

19.31

1.3

1.4

15.75

17.33

pmol/l

0.14

140

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

168

688

2.17

19.25

3.5

2.8

10.19

10.31

kpa

0.18

168

688

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

168

688

2.17

19.25

3.5

2.8

5.04

4.94

kpa

0.57

168

688

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

928

6000

1.38

18.93

2.6

2.5

3.60

3.62

g/l

0.11

878

5760

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

194

848

2.03

18.77

1.8

1.4

2792538.46

2088957.97

iu/ml

0.16

(4268621) Lupus anticoagulant assay

346

1817

1.70

18.73

2.4

2.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

807

5108

1.41

18.65

1.8

1.9

13.55

13.56

iu/l

0.00

316

1988

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

689

4245

1.45

18.47

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

285

1427

1.78

18.27

1.3

485.77

512.37

titre

0.04

114

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

480

2752

1.56

18.23

1.4

1.3

0.19

0.25

nmol/l

0.82

213

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

188

822

2.03

18.19

1.6

2.85

7.83

nmol/l

1.02

148

695

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3274

24827

1.19

18.10

1.7

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1829

13090

1.26

17.90

1.3

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

470

2698

1.55

17.77

1.4

1.3

1.53

1.52

nmol/l

0.00

447

2602

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

535

3170

1.51

17.48

1.1

—

(3010421) pH of Blood

1035

6914

1.34

17.16

4.1

3.7

7.41

0.70

1015

6822

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

663

4114

1.44

17.14

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

275

1390

1.76

17.11

1.3

68.00

68.25

titre

0.00

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

427

2420

1.57

17.10

1.1

120.01

117.16

1.07

391

2173

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1896

13697

1.24

17.07

2.3

2.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

6.19

16.98

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8798

71935

1.13

16.93

5.6

5.8

3.14

3.68

ug/l

0.86

7878

64768

(3011985) Renin [Units/volume] in Plasma

483

2825

1.52

16.80

1.5

59.57

61.25

mu/l

0.07

435

2518

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

299

1558

1.71

16.72

1.2

98.99

108.42

pmol/l

2.68

299

1558

(3026389) Candida sp identified in Specimen by Organism specific culture

477

2787

1.53

16.68

1.5

1.4

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

111

3.92

16.55

1.2

41.77

19.16

1.26

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

236

2.90

16.29

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

586

3595

1.45

16.13

1.7

1.9

4.91

4.99

mmol/24h

0.14

500

3166

(43055514) Macroprolactin [Presence] in Serum or Plasma

297

2.66

16.08

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1091

7420

1.32

15.98

2.3

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

437

2530

1.54

15.96

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1737

12522

1.25

15.93

2.2

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

845

5542

1.36

15.82

1.2

121.06

133.64

titre

0.26

508

(3020717) Zinc [Moles/volume] in Serum or Plasma

208

991

1.87

15.75

1.6

1.4

17.03

23.37

umol/l

3.45

192

918

(40767503) Oxygen content in Capillary blood by calculation

726

4650

1.39

15.73

2.9

2.7

16.47

16.19

1.77

701

4563

(3022806) Fractional oxyhemoglobin in Capillary blood

434

2519

1.54

15.68

2.2

1.8

88.91

89.28

0.62

427

2482

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

1159

1.80

15.64

1.5

1.4

1.17

1.24

nmol/l

0.40

170

870

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

108

3.86

15.59

1.8

1.3

43.69

37.40

0.38

(3000475) Leukocytes [#/volume] in Synovial fluid

832

5462

1.36

15.49

1.7

1.6

14861.99

14477.02

e6/l

0.08

575

3877

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

446

2613

1.52

15.44

1.3

313.74

337.32

pmol/l

0.23

370

2222

(3027315) Oxygen [Partial pressure] in Blood

718

4611

1.39

15.32

4.5

4.1

8.46

8.51

kpa

0.42

696

4509

(3036180) Methadone [Presence] in Urine

17.73

15.29

4.7

2.7

—

(3012501) Base excess in Blood by calculation

713

4587

1.39

15.06

4.5

4.1

2.53

2.62

mmol/l

0.39

489

3144

(3013290) Carbon dioxide [Partial pressure] in Blood

713

4589

1.39

15.02

4.5

4.1

5.03

5.00

kpa

0.44

692

4487

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

547

3361

1.45

14.96

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

410

2376

1.54

14.94

1.3

0.19

0.21

nmol/l

1.01

337

1895

(3008116) Ketones [Moles/volume] in Urine by Test strip

108

410

2.34

14.93

1.7

1.3

0.30

0.27

mmol/l

0.08

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

258

1335

1.72

14.86

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

244

1245

1.74

14.77

2.1

2.0

8.00

8.24

mmol/l

0.41

244

1245

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

158

702

2.00

14.74

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

221

1101

1.79

14.53

1.4

1.5

7.14

5.85

u/l

0.50

185

936

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

904

6081

1.33

14.34

1.4

1.5

8.37

14.52

iu/ml

0.90

134

(3034770) Mitochondria Ab [Titer] in Serum

826

5485

1.35

14.30

1.2

555.29

953.05

titre

1.36

164

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

804

5340

1.34

13.92

1.5

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

209

1040

1.79

13.83

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

394

2304

1.52

13.81

1.3

—

nmol/l

—

(3052592) Norovirus Ag [Presence] in Stool

370

2.35

13.76

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

382

2222

1.53

13.73

3.5

3.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2854

21885

1.17

13.62

4.3

3.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.62

13.43

1.2

1.1

—

mmol/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1826

13472

1.22

13.41

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

439

2645

1.48

13.34

2.0

2.1

24.13

27.31

mg/l

0.65

144

989

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

3.79

13.30

1.9

1.3

18.61

11.62

0.62

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

3.97

13.12

1.7

1.2

2.48

1.42

0.36

(3006270) Folate [Moles/volume] in Blood

287

1580

1.62

13.11

1.2

358.08

341.70

nmol/l

0.64

236

1289

(3000093) Morphology [Interpretation] in Blood Narrative

366

2141

1.52

12.85

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

642

4173

1.37

12.80

1.3

1.2

37.90

45.64

u/ml

0.65

375

(40768443) Skin Pathology biopsy report

1338

9610

1.25

12.70

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

164

779

1.87

12.65

1.5

2.0

160.45

163.45

0.15

156

731

(1616796) Gas panel - Central venous blood

761

5092

1.33

12.57

3.8

3.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

229

1204

1.69

12.53

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

327

1878

1.55

12.50

1.1

97.64

96.42

0.34

302

1754

(3016244) Insulin [Units/volume] in Serum or Plasma

176

859

1.82

12.47

3.3

3.1

23.54

27.08

mu/l

0.71

161

805

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

803

5426

1.32

12.39

1.9

2.0

12.13

11.96

mg/l

0.24

745

5054

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

226

1190

1.69

12.31

1.3

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

205

1052

1.73

12.26

2.1

95.45

97.37

0.31

195

998

(3033923) Metanephrine [Moles/time] in 24 hour Urine

348

2.30

12.03

1.2

1.1

0.66

0.86

umol/24h

0.50

161

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

288

1623

1.58

11.98

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

924

6407

1.29

11.79

1.8

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

335

1966

1.52

11.64

3.0

2.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

853

5866

1.30

11.60

1.3

35.68

40.27

u/ml

0.17

298

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

118

518

2.02

11.50

2.1

2.6

1.00

1.02

ug/l

0.04

111

492

(3000492) Spirometry study

2381

18238

1.17

11.45

1.6

1.5

—

17.22

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

403

2.16

11.33

1.2

—

(3037121) Protein [Mass/volume] in Urine

1041

7365

1.26

11.29

3.1

3.3

883.72

564.95

mg/l

0.39

453

3368

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

538

3475

1.38

11.21

1.3

1.5

4.32

14.42

u/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

623

4136

1.34

10.91

1.4

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.7

1.6

2.81

1.49

mg/l

0.50

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.7

1.6

2.88

2.20

mg/l

0.25

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.7

1.6

3.13

2.55

mg/l

0.20

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.7

1.6

1.45

2.78

mg/l

0.88

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.7

1.6

1.75

2.01

mg/l

0.14

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.6

2.11

1.87

mg/l

0.07

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.7

1.6

3.70

3.92

mg/l

0.06

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.7

1.6

1.49

0.92

mg/l

0.25

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

106

3.35

10.89

1.6

1.48

0.72

mg/l

0.32

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

340

2031

1.49

10.88

1.4

24.11

31.26

u/l

3.92

262

1679

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

124

566

1.95

10.85

1.6

2.0

175.05

188.32

0.72

119

536

(3044941) Cell count panel - Synovial fluid

582

3829

1.35

10.82

1.6

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

108

3.28

10.59

1.6

2.04

1.81

mg/l

0.08

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

160

799

1.78

10.59

1.8

1.7

29.54

29.05

umol/l

0.26

148

751

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

123

568

1.92

10.43

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

314

4080

0.68

10.41

1.6

991.83

1005.61

mu/l

0.07

249

3439

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.17

9.98

1.3

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

344

2.17

9.88

2.2

2.0

1.20

1.19

mmol/l

0.74

331

(3003129) Base excess in Capillary blood by calculation

412

2605

1.41

9.81

2.3

0.78

0.44

mmol/l

1.00

396

2504

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.88

9.81

1.6

199.25

219.19

nmol/l

0.14

(3022145) Colonoscopy Study observation

3022

23834

1.14

9.68

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

186

996

1.66

9.63

1.1

3.27

4.10

iu/ml

0.47

(3051339) Copper [Moles/volume] in Blood

3.48

9.58

1.1

17.04

16.76

umol/l

0.16

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

165

857

1.71

9.58

1.2

1.1

1579.79

1540.94

miu/ml

0.15

165

857

(3017315) Amylase [Enzymatic activity/volume] in Urine

186

998

1.66

9.56

1.1

1.2

241.72

353.49

u/l

0.89

169

928

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

498

3266

1.36

9.51

1.2

0.42

1.04

3.41

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

252

1457

1.54

9.48

1.2

—

(3023419) Bacteria identified in Sputum by Culture

445

2868

1.38

9.48

2.4

2.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

428

2742

1.39

9.46

1.1

24.78

16.39

au/ml

0.72

602

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

259

1509

1.53

9.41

1.2

—

(3028433) Virus identified in Specimen by Culture

127

615

1.83

9.36

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

634

7246

0.77

9.36

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

259

1511

1.52

9.36

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

142

2132

0.59

9.11

1.5

1.11

1.16

ratio

0.21

1284

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

177

951

1.65

9.08

1.1

1.07

ratio

0.42

152

767

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

416

2672

1.39

9.07

1.4

—

(3022621) pH of Urine by Test strip

2095

16188

1.16

8.98

3.1

2.7

6.13

6.04

4.22

1458

11095

(3017509) Phencyclidine [Presence] in Urine

126

2.89

8.82

2.7

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

740

5184

1.27

8.81

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

144

2135

0.60

8.81

1.5

0.90

0.94

ratio

0.72

1287

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

144

2135

0.60

8.81

1.5

1.06

1.23

ratio

1.59

1296

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.90

8.72

1.9

2.1

192.95

260.07

ug/l

0.88

(4062490) Immunoglobulin typing, IgG

324

2008

1.43

8.69

1.5

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

780

5510

1.26

8.67

1.3

3.68

6.45

u/ml

1.07

533

(3024980) IgG subclass 4 [Mass/volume] in Serum

504

3362

1.33

8.65

1.5

1.6

0.79

0.81

g/l

0.12

380

2599

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

146

757

1.71

8.58

1.5

1.2

3.72

4.17

umol/l

0.86

129

664

(3044927) Protein electrophoresis panel - Urine

358

2265

1.41

8.56

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1572

1.49

8.51

1.1

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

243

1429

1.51

8.51

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

836

5967

1.25

8.50

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

622

4283

1.29

8.50

2.0

1.9

195.69

199.25

pmol/l

0.29

583

4045

(40759836) Histone Ab [Presence] in Serum by Immunoblot

259

1545

1.49

8.47

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

143

2101

0.60

8.45

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

158

2266

0.62

8.45

1.5

57.92

59.99

ug/l

0.18

123

1889

(3006922) Hepatitis E virus Ab [Presence] in Serum

251

1489

1.50

8.44

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

389

2503

1.38

8.43

1.3

1.4

—

(4035726) Immunohistochemistry procedure

1909

19363

0.86

8.37

1.3

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

133

677

1.74

8.36

1.3

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

265

1593

1.48

8.35

1.2

165.23

193.89

titre

0.24

280

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

203

2.40

8.30

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

328

2058

1.42

8.25

1.5

1.4

2.83

2.92

g/l

0.42

235

1472

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

224

1305

1.53

8.21

1.2

1.3

23.82

27.56

u/l

0.56

183

1100

(3005988) Vibrio sp identified in Specimen by Organism specific culture

389

2515

1.38

8.20

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

402

2613

1.37

8.20

1.3

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

464

3085

1.34

8.17

1.5

3566.16

2484.28

e6/l

0.46

325

2187

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

228

1336

1.52

8.14

1.2

1.3

94.08

97.42

u/l

0.17

193

1147

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

563

3849

1.30

8.14

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

388

2514

1.37

8.08

1.3

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

506

3413

1.32

8.08

2.3

2.7

2300.74

4891.07

u/ml

0.38

211

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

179

995

1.60

8.07

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

179

995

1.60

8.07

1.3

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1476

1.49

8.04

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

380

1.99

8.03

1.4

1.3

77.60

54.16

mg/l

0.19

275

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

263

1592

1.47

8.02

1.2

285.71

149.44

titre

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

424

2793

1.35

7.96

1.2

5.21

11.32

u/ml

1.31

116

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

771

5499

1.25

7.92

1.3

4.33

7.78

u/ml

2.49

106

817

(3027135) IgG subclass 1 [Mass/volume] in Serum

326

2059

1.41

7.92

1.5

1.4

6.65

6.83

g/l

0.37

236

1470

(3024139) IgG subclass 3 [Mass/volume] in Serum

326

2059

1.41

7.92

1.5

1.4

0.37

0.43

g/l

1.42

235

1471

(3008898) HLA-B27 [Presence]

748

5319

1.25

7.89

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

401

2623

1.36

7.88

1.3

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

158

858

1.64

7.85

1.2

1.3

145.87

163.72

mmol/24h

1.67

158

858

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

512

3475

1.31

7.83

1.2

1.3

279.67

274.23

u/ml

0.15

298

2177

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

193

1102

1.56

7.78

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

193

1103

1.55

7.75

1.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

370

2399

1.37

7.70

1.3

43.18

60.15

u/ml

0.54

150

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

127

2.72

7.60

1.2

1.1

1.67

1.63

iu/ml

0.04

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

257

2.17

7.59

1.6

1.7

1.20

1.11

nmol/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

285

1772

1.43

7.58

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

873

6344

1.23

7.56

1.4

30.10

30.50

iu/l

0.12

729

5415

(3017704) Immunofixation for Urine

210

1232

1.51

7.50

1.4

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

119

1770

0.59

7.45

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

125

648

1.71

7.42

1.0

1.1

102.62

96.61

1.02

101

497

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

584

1.75

7.35

1.3

0.32

0.31

g/l

0.62

478

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

127

664

1.70

7.32

1.8

2.1

29.99

29.89

0.03

122

631

(3045788) Cell count panel - Pleural fluid

377

2473

1.36

7.31

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

124

1810

0.61

7.22

1.5

1.6

—

(40757373) Influenza virus identified in Isolate

389

1.92

7.22

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

540

3735

1.29

7.20

1.2

23.74

54.35

u/ml

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

290

1827

1.41

7.19

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

290

1827

1.41

7.19

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

290

1827

1.41

7.19

1.6

—

(3005570) Glucose [Moles/volume] in Urine

321

2059

1.39

7.17

2.4

1.9

—

0.76

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

218

2.24

7.12

1.3

1.2

96.51

100.07

ug/l

0.08

131

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

356

2325

1.36

7.12

1.2

62.54

60.35

u/l

0.26

308

2046

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

109

551

1.76

7.09

1.4

1.2

108.03

111.25

0.58

492

(3013005) Retinol [Moles/volume] in Serum or Plasma

147

806

1.62

7.08

2.0

1.7

2.08

1.96

umol/l

1.09

132

743

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

136

732

1.65

7.05

1.1

2.18

13.81

u/ml

1.58

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

170

2.40

6.98

1.3

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

770

5575

1.23

6.95

1.9

1.8

43.09

42.54

nmol/l

0.24

740

5427

(3005033) Fetal Nuchal fold Thickness US

119

1735

0.61

6.92

1.5

1.21

1.26

0.52

1250

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

372

2459

1.35

6.89

2.1

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

283

1790

1.41

6.88

1.4

13.49

13.13

u/l

0.33

271

1737

(3006576) Bicarbonate [Moles/volume] in Blood

135

730

1.64

6.88

5.9

6.7

24.95

25.09

mmol/l

0.17

120

662

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2204

17410

1.13

6.87

4.2

4.0

1.22

1.23

mmol/l

1.19

1938

14913

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

211

2.23

6.81

3.0

2.1

0.94

1.16

mmol/l

0.40

143

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2129

16792

1.13

6.79

2.5

2.2

12.54

12.75

nmol/l

0.52

1858

14990

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

245

1514

1.44

6.79

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

621

4406

1.25

6.75

4.6

5.5

562.09

1307.74

iu/ml

1.04

673

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

312

2014

1.38

6.74

1.4

1.3

1.37

1.46

nmol/l

0.72

276

1817

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

322

2090

1.37

6.72

1.5

1.4

0.26

0.34

nmol/l

2.03

244

1530

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

231

1418

1.45

6.65

1.8

1.9

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

703

5073

1.23

6.57

1.3

30.04

10.14

u/ml

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

102

2.78

6.53

1.2

0.43

0.64

iu/ml

0.52

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

139

2.49

6.42

1.0

1.1

13.26

9.90

u/l

0.29

139

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

184

1089

1.50

6.38

2.1

1.9

2.27

2.87

u/field

0.54

147

736

(3020911) Cortisol [Moles/time] in 24 hour Urine

117

624

1.66

6.33

1.5

1.4

92.72

225.46

nmol/24h

1.40

117

624

(3019420) Tryptase [Mass/volume] in Serum or Plasma

168

979

1.52

6.28

1.6

9.72

9.64

ug/l

0.01

160

899

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

543

3828

1.26

6.27

1.3

1.4

15.82

24.38

u/ml

0.93

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

257

1629

1.40

6.23

3.7

5.6

44.99

122.18

u/ml

2.30

535

(3006245) CD3-CD19+ cells/cells in Blood

123

668

1.63

6.21

1.8

2.2

9.50

10.61

0.66

117

618

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

656

4732

1.23

6.18

1.3

1.2

1.44

4.99

u/ml

2.75

313

(3000060) B lymphocytes [#/volume] in Blood

463

1.76

6.14

1.7

2.2

0.16

0.86

e9/l

1.20

231

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2112

16758

1.13

6.13

2.8

64.64

63.18

ml/min/173m2

0.97

949

7135

(3015956) Eosinophils/Leukocytes in Blood by Manual count

276

1.99

6.04

2.4

2.56

2.79

0.17

271

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

395

1.82

6.01

1.2

1.3

1.18

mmol/l

0.01

395

(3029075) Extractable nuclear Ab panel - Serum

193

1169

1.47

6.00

1.1

—

0.40

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.17

5.99

1.2

1.4

161.60

112.38

nmol/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

325

2157

1.34

5.94

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

225

1407

1.42

5.91

2.3

2.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

306

2015

1.35

5.89

1.3

1.2

31.60

36.43

nmol/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

279

1.97

5.87

1.1

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

134

756

1.57

5.82

2.8

2.7

0.60

0.61

mmol/l

0.73

134

756

(40768795) Lymph node Pathology biopsy report

171

2216

0.68

5.82

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

217

2695

0.71

5.81

1.7

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

502

3544

1.26

5.77

1.4

1.5

31.08

41.14

g/l

0.62

444

3232

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

346

2330

1.32

5.73

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.78

5.71

1.7

1.3

1.57

2.13

g/l

0.68

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

176

2.22

5.66

1.6

2.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

417

1.77

5.61

1.2

526.13

295.48

pmol/l

0.63

301

(40768804) Tissue Pathology biopsy report

9513

80873

1.07

5.61

2.3

2.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

100

531

1.67

5.56

1.1

87.62

85.49

0.23

270

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

511

1.68

5.55

1.3

37.09

37.73

0.05

342

(40761539) Cells [Type] in Urine sediment by Light microscopy

498

1.69

5.54

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

101

539

1.66

5.51

1.1

1.2

105.57

104.90

0.07

498

(44806071) Cardiolipin IgM antibody measurement

237

2.02

5.50

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

464

5142

0.80

5.49

2.7

3.5

244.27

1182.75

u/ml

3.68

410

4668

(3022493) Free Hemoglobin [Mass/volume] in Plasma

159

946

1.49

5.45

6.0

3.2

65.68

991.52

mg/l

1.37

114

660

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

489

3468

1.25

5.43

1.4

151.88

151.65

au/ml

0.01

139

997

(3032057) Clostridioides difficile [Presence] in Stool

422

1.74

5.41

1.7

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

541

3883

1.24

5.40

1.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.32

5.38

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

112

620

1.60

5.31

1.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

555

4010

1.23

5.22

1.2

1.3

140.00

148.57

titre

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

11.39

5.18

1.2

1.0

—

(44806420) Estimation of glomerular filtration rate

154

1987

0.68

5.17

2.7

2.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

527

3794

1.24

5.14

1.4

1.6

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.40

5.12

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

401

2800

1.27

5.10

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

190

2.10

5.10

1.4

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

519

1.64

5.03

1.1

1.2

90.64

85.21

0.51

267

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

536

3882

1.23

4.95

1.3

34.79

35.84

u/l

0.08

480

3348

(3028308) Erythrocytes [#/volume] in Pleural fluid

396

2775

1.27

4.91

1.5

66761.52

58927.06

e6/l

0.20

223

1580

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

242

1.94

4.88

3.5

2.8

0.68

0.48

u/field

0.73

242

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

549

3995

1.22

4.86

1.2

1.3

185.00

273.93

titre

0.73

309

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

299

1.84

4.85

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

159

2.17

4.84

1.1

1.86

1.72

umol/24h

0.32

159

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

274

1.88

4.84

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

310

2110

1.31

4.83

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

275

1.87

4.79

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

200

1277

1.39

4.76

1.9

2.6

229.64

235.54

e6/l

0.16

164

1113

(3013336) Amino acids [Identifier] in Serum or Plasma

4.77

4.66

2.7

3.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

550

4022

1.22

4.65

2.2

1.7

0.85

0.86

nmol/l

0.07

449

3400

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1121

0.61

4.61

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.58

4.51

1.6

1.5

0.29

0.23

u/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

150

920

1.45

4.49

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

522

1.60

4.47

1.3

1.5

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

119

2.31

4.45

1.0

1.1

45.29

102.17

u/l

0.53

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

201

1301

1.37

4.44

1.5

1.6

7.05

6.78

u/l

0.09

155

1032

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

414

1.67

4.43

1.2

—

(3014891) Appearance of Pleural fluid

328

1.76

4.42

1.6

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

279

1903

1.30

4.33

1.3

13.81

14.11

u/l

0.08

248

1775

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

210

1375

1.36

4.33

1.5

1.3

0.76

1.77

u/ml

2.15

141

800

(4034850) Laboratory test

800

6093

1.17

4.31

10.7

11.5

—

(3024263) Appearance of Synovial fluid

168

1062

1.40

4.29

1.5

1.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

358

1.71

4.28

1.1

1.2

107.83

79.04

3.14

113

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

286

1.80

4.27

1.0

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

116

2.29

4.25

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

287

1.79

4.23

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

287

1.79

4.23

1.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

224

1.90

4.20

1.9

1.6

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

169

2.05

4.20

2.2

1.7

1.37

1.36

umol/l

0.02

122

(21491868) Cryoglobulin [Mass/volume] in Serum

120

716

1.49

4.17

1.2

1.02

0.44

g/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

200

1.95

4.16

1.8

2.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

357

1.69

4.06

1.1

1.2

87.11

67.98

1.75

112

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

345

2439

1.26

4.06

2.9

3.6

4.74

11.85

nmol/l

1.47

326

2371

(37021550) Renin [Units/volume] in Plasma --upright

358

1.68

4.02

1.3

98.16

62.07

mu/l

0.69

259

(3017569) Oxygen content in Arterial blood

201

1324

1.35

4.02

2.1

2.2

16.22

15.72

1.40

201

1324

(3010144) Erythrocytes [#/volume] in Synovial fluid

295

2050

1.28

4.01

1.4

236458.02

111218.36

e6/l

1.47

194

1377

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

126

2.18

3.94

1.5

1.3

22.03

22.38

mmol/l

0.12

(3024316) Viscosity of Plasma

2.45

3.93

1.4

2.0

1.57

1.78

mpas

—

(3036603) Volume of Urine

236

1598

1.31

3.91

1.5

1.6

1917.91

1926.78

0.03

228

1559

(3034426) Prothrombin time (PT)

499

1.56

3.89

1.3

1.2

29.51

28.43

0.89

499

(3000034) Microalbumin [Mass/volume] in Urine

262

1801

1.29

3.89

3.1

2.9

36.61

52.86

mg/l

0.91

179

1299

(4094501) Cardiovascular stress test using bicycle ergometer

714

5439

1.17

3.88

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

341

2423

1.25

3.86

1.3

1.4

6.60

6.27

mmol/l

1.34

312

2271

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

148

934

1.41

3.86

1.1

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.02

3.84

1.1

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

539

1.53

3.75

1.2

8.55

13.65

pmol/l

1.23

200

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

279

1.75

3.74

1.6

1.9

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.61

3.73

1.1

1.0

173.53

141.35

pmol/l

0.47

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

519

1.54

3.71

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

189

1251

1.34

3.69

1.9

2.5

590.11

532.30

e6/l

0.42

147

1023

(3029634) Reagin Ab [Titer] in Serum by VDRL

336

2398

1.24

3.68

2.1

2.2

16.80

6.86

titre

—

(21494890) Protein electrophoresis panel - 24 hour Urine

340

2431

1.24

3.66

1.8

2.2

—

(40768800) Prostate Pathology biopsy report

472

4984

0.84

3.61

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

143

2.05

3.60

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

2.79

3.59

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

163

1.96

3.49

1.5

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

134

848

1.40

3.48

1.2

1.3

5.82

5.95

mmol/l

0.91

124

805

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

7.75

3.47

1.0

1.1

25.86

18.50

umol/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

228

1568

1.29

3.43

1.2

1.3

9.79

9.15

mmol/l

1.14

213

1472

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

382

2792

1.22

3.37

1.1

1.57

1.53

g/l

0.86

335

2555

(3026692) Albumin [Mass/volume] in Peritoneal fluid

104

633

1.46

3.35

1.5

1.4

12.63

14.03

g/l

0.84

485

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

795

6180

1.14

3.34

1.5

1.49

9.86

iu/ml

1.37

174

1208

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

296

1.68

3.33

1.2

1.3

135.23

135.51

ng/l

0.00

194

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

101

2.19

3.27

1.0

1.1

—

(3032641) Amino acids panel - Urine

8.86

3.23

1.3

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

187

1.85

3.23

1.6

1.7

45.59

45.84

umol/l

0.02

187

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

252

1.72

3.22

1.7

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

364

1.58

3.11

1.4

427.20

405.45

titre

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.22

3.09

1.3

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

514

1.48

3.07

1.2

1.1

2.60

5.67

u/ml

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

422

1.53

3.05

2.1

2.4

7.50

7.51

mmol/l

0.01

270

(40768793) Breast Pathology biopsy report

447

4662

0.85

3.03

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

135

1.97

3.00

1.1

1.0

0.03

0.04

u/ml

0.56

135

(3020876) Protein [Mass/time] in 24 hour Urine

397

2950

1.20

3.00

2.1

2.4

1.18

g/24h

0.01

221

1748

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

332

2426

1.22

2.99

1.3

414.44

473.56

u/l

0.31

305

2319

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

203

1404

1.28

2.98

2.2

2.0

14.69

16.22

1.25

198

1366

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.37

2.97

1.1

1.0

0.01

0.19

u/ml

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

547

1.46

2.97

1.4

40.65

27.21

g/l

0.35

432

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

199

1.78

2.97

1.3

1.4

0.18

0.24

nmol/l

0.54

136

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.58

2.96

1.2

26.62

61.38

umol/24h

0.71

(3013166) Neutrophils/Leukocytes in Synovial fluid

594

1.43

2.90

1.4

62.40

57.67

0.63

506

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

654

5072

1.15

2.89

1.5

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.27

2.86

1.6

1.4

187.60

102.13

ug/l

0.70

(3023487) Leukocytes [#/volume] in Peritoneal fluid

133

876

1.35

2.79

2.1

1.9

1795.97

2704.40

e6/l

0.23

596

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

584

4508

1.15

2.78

1.3

221.08

219.33

miu/ml

0.03

188

1883

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

156

1796

0.77

2.74

1.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.28

2.74

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

252

1811

1.24

2.71

1.1

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.08

2.69

1.3

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

130

1527

0.75

2.66

1.4

1.5

56.33

59.56

ug/l

0.35

130

1527

(3004775) Volume in Urine collected for unspecified duration

151

1737

0.77

2.65

2.1

2.3

685.62

666.32

0.20

1163

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

168

1155

1.29

2.63

2.3

2.8

41.54

37.94

1.49

102

651

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

246

1776

1.23

2.55

2.1

2.10

3.26

u/field

0.38

153

934

(4212803) Bone marrow aspirate examination

203

1.70

2.53

1.2

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

575

1.40

2.50

1.6

—

79.71

iu/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

378

2849

1.18

2.49

1.5

—

(3044007) Cell count panel - Peritoneal fluid

112

735

1.35

2.45

2.0

1.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.16

2.45

1.1

1.0

4.44

5.34

mmol/l

0.90

(3035880) pH of Pleural fluid

189

1333

1.26

2.44

1.2

1.3

7.44

7.40

2.29

130

955

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

141

0.31

2.42

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

256

1870

1.22

2.40

2.3

1264.43

1157.88

e6/l

0.68

221

1676

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

558

1.40

2.38

1.4

1.9

5.92

313.61

pmol/l

1.49

118

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.66

2.37

1.2

1.1

2.25

2.85

0.40

(3034274) Bile acid [Moles/volume] in Serum --fasting

213

1530

1.24

2.35

1.8

2.0

8.29

9.23

umol/l

0.25

159

1124

(1175426) CD3 cells/Lymphocytes in Blood

207

1483

1.24

2.34

2.3

2.0

74.30

71.46

2.23

201

1417

(3023383) Lactate [Moles/volume] in Pleural fluid

113

749

1.34

2.34

1.3

3.98

3.43

mmol/l

0.57

103

694

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

177

1961

0.80

2.33

1.4

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.33

2.31

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

291

2163

1.19

2.29

1.2

59.11

40.29

u/ml

0.56

108

(3041918) Cholesterol [Moles/volume] in Pleural fluid

474

1.42

2.28

1.2

1.3

1.42

1.62

mmol/l

0.92

312

(3027231) Wheat IgE Ab [Units/volume] in Serum

265

1.57

2.28

1.1

1.0

0.59

1.98

u/ml

0.72

225

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

336

1.50

2.27

1.2

1.3

50.82

156.71

u/l

0.62

256

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

324

2434

1.18

2.26

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

736

5855

1.12

2.25

1.8

1.7

4.13

4.64

mg/l

0.54

595

4341

(3003843) Paprika IgE Ab [Units/volume] in Serum

3.19

2.25

1.0

0.25

0.04

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

174

1230

1.26

2.23

1.1

28.13

24.03

u/l

0.34

153

1089

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

476

1.42

2.23

2.2

2.4

352.63

248.10

ug/l

0.15

476

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

145

1.77

2.19

1.5

11.76

16.81

pmol/l

1.22

129

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.05

2.19

1.2

1.1

228.63

266.24

nmol/l

0.73

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

321

2418

1.18

2.18

1.1

1.68

2.86

1.87

345

(3002621) Streptococcal DNAse B [Units/volume] in Serum

192

1.66

2.18

1.1

1.0

327.00

304.72

u/ml

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

391

0.57

2.18

1.7

1.4

11.91

11.32

0.05

202

(3051101) Glucose [Moles/volume] in Cord blood

413

0.58

2.17

4.3

5.8

8.34

8.59

mmol/l

0.19

413

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

554

1.38

2.16

10.3

7.6

6.01

5.99

kpa

0.07

488

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4989

42619

1.05

2.14

3.3

0.74

0.81

ug/l

4.68

3573

28995

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

563

4425

1.13

2.13

1.4

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

184

1317

1.24

2.13

1.1

1.2

85.00

82.70

0.20

(40761995) Spermatozoa Progressive [#/volume] in Semen

260

0.48

2.11

4.0

3.0

35.00

44.21

1.29

260

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

174

1240

1.24

2.10

1.1

88.79

83.87

u/l

0.22

150

1098

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.30

2.10

1.0

1.1

1.36

1.15

u/field

0.47

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

259

0.48

2.09

8.0

6.1

15.57

8.61

1.79

259

(3008037) Lactate [Moles/volume] in Venous blood

686

5464

1.12

2.08

4.2

3.1

1.63

1.60

mmol/l

0.27

676

5332

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

195

1.64

2.07

1.0

0.40

0.48

u/ml

0.06

129

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.15

2.07

2.0

4.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

171

1220

1.24

2.06

1.1

8.74

8.43

iu/ml

0.05

293

(3045683) HLA typing for celiac disease panel - Blood or Tissue

130

902

1.28

1.99

1.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.90

1.98

1.1

1.6

141.19

212.94

ug/g

1.71

(3010370) Gastrin [Moles/volume] in Serum or Plasma

319

1.47

1.95

1.8

1.9

48.99

52.02

pmol/l

0.10

265

(3019768) Coxiella burnetii Ab [Presence] in Serum

118

1.80

1.94

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

227

1.56

1.93

1.1

1.0

93.44

81.40

ug/l

0.81

166

(4281824) Cell count and differential, peritoneal fluid

221

2339

0.84

1.92

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

560

0.66

1.92

1.4

1.5

—

(44813793) Dust mix specific IgE antibody measurement

174

1256

1.23

1.91

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

637

5085

1.11

1.89

2.2

2.4

111.80

113.26

ug/min

0.03

332

2975

(40762814) Titanium [Mass/volume] in Blood

396

0.60

1.88

2.3

2.5

5.01

3.38

ug/l

0.46

130

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

538

1.35

1.88

1.5

1.6

0.41

0.39

ug/l

0.29

383

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

173

1.64

1.88

1.2

1.5

—

(3049233) Organic acids panel - Urine

4.43

1.87

1.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

403

4062

0.88

1.87

1.4

150.24

177.19

pmol/l

0.59

390

3959

(1617658) Protocol used for examination of sentinel lymph nodes

130

1445

0.80

1.84

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

135

1.71

1.78

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.57

1.77

1.9

1.5

2.14

1.95

mmol/24h

—

(1761482) Bacteria [#/volume] in Urine by Culture

551

5429

0.90

1.77

6.0

4.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

110

761

1.28

1.76

2.0

1.8

9589.64

11925.02

e6/l

0.19

405

(40768806) Pleura Pathology biopsy report

345

2667

1.15

1.75

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.05

1.74

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

380

2960

1.14

1.73

1.1

60.88

4917.75

iu/ml

0.65

560

(3026051) Granulocytes/Leukocytes in Pleural fluid

539

1.33

1.72

1.3

1.4

19.73

21.65

0.27

458

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

117

1.74

1.70

1.0

0.15

0.12

u/ml

0.15

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1012

8309

1.08

1.68

3.1

3.6

237.18

1974.17

u/ml

3.50

840

7175

(3010375) cycloSPORINE [Mass/volume] in Blood

121

854

1.26

1.67

27.5

30.7

105.71

113.77

ug/l

0.91

715

(3042010) Triglyceride [Moles/volume] in Pleural fluid

383

1.39

1.66

1.2

1.3

1.22

1.30

mmol/l

0.05

265

(3019174) dRVVT (LA screen)

138

1.67

1.66

1.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

166

1.60

1.64

2.3

2.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

415

1.37

1.62

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.86

1.62

1.0

0.23

0.10

u/ml

0.46

(3004616) Nuclear Ab [Presence] in Serum

330

2561

1.14

1.61

1.3

—

(3004451) EKG impression Narrative

174

1283

1.20

1.60

1.2

1.3

—

(3000330) Specific gravity of Urine by Test strip

1144

10845

0.93

1.57

4.4

3.5

1.02

ratio

0.87

1018

9781

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

380

1.38

1.57

7.0

6.9

10.49

0.01

380

(4015189) Microbial culture of sputum

572

1.30

1.55

2.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

141

0.44

1.55

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

107

752

1.26

1.55

1.0

1.1

11.30

6.53

u/ml

0.44

115

(3038026) Centromere Ab [Units/volume] in Serum

207

1556

1.18

1.55

1.2

32.54

48.89

u/ml

—

101

(3008757) Leukocyte morphology finding [Identifier] in Blood

299

2314

1.15

1.54

3.9

3.8

—

(3047189) Immunofixation for 24 hour Urine

147

1072

1.22

1.53

1.4

1.8

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

128

1.66

1.53

1.4

1.2

18.40

15.98

nmol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

934

0.78

1.49

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

102

1.74

1.49

1.3

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

150

1.60

1.48

1.0

2.50

8.21

u/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

155

1141

1.20

1.48

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

154

1133

1.21

1.48

5.4

7.2

202.18

104.14

ug/l

0.22

744

(40761536) Microorganisms panel - Urine sediment

1777

16575

0.95

1.47

5.4

4.1

—

(3002619) Bacteria identified in Specimen by Culture

546

1.30

1.47

1.2

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.42

1.47

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.75

1.46

1.1

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

215

0.54

1.46

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

594

1.28

1.45

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

181

1.52

1.39

3.3

6.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

276

1.41

1.39

1.3

1.4

78.97

72.49

0.80

231

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

775

6356

1.08

1.38

3.1

3.2

1.65

1.64

mg/l

0.07

699

5757

(3036071) Salmonella sp Ab [Titer] in Serum

521

1.29

1.37

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

370

2929

1.12

1.37

2.6

2.7

188.99

830.42

u/ml

1.16

363

2896

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

146

0.49

1.36

1.4

1.2

50.38

72.30

ug/l

—

146

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.73

1.35

1.2

1.5

1.13

1.11

u/field

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

311

2443

1.13

1.32

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

359

2848

1.12

1.30

1.3

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.77

1.29

1.4

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

273

2740

0.88

1.29

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

114

1.63

1.28

1.0

0.17

0.74

u/ml

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

488

1.29

1.28

11.1

7.3

6.03

5.45

kpa

0.72

488

(3002523) Influenza virus A Ag [Presence] in Specimen

273

2738

0.88

1.28

1.1

—

(3025130) Human papilloma virus identified in Specimen

284

2228

1.13

1.25

1.7

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

104

752

1.23

1.2

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

398

1.31

1.23

1.3

1.6

113.83

107.15

ug/l

0.17

323

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

130

1.57

1.21

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

116

1.60

1.21

1.1

1.0

1.01

1.15

u/ml

0.05

(3017354) Segmented neutrophils/Leukocytes in Blood

312

2468

1.12

1.21

3.2

3.5

60.45

57.82

1.42

261

2117

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.15

1.20

2.5

1.28

4.18

mu/l

—

(3020393) Adenovirus Ag [Presence] in Stool

196

1.45

1.18

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

126

1326

0.84

1.15

1.9

1.6

3.35

4.26

ug/l

0.57

1086

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

177

1354

1.16

1.15

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

682

0.78

1.14

1.6

5333.33

3368.07

titre

—

119

(3020491) Glucose [Moles/volume] in Blood

182

1397

1.16

1.13

2.1

1.9

7.22

7.09

mmol/l

0.25

142

978

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

577

1.24

1.12

1.6

2.0

34.63

39.20

u/l

0.08

534

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

498

1.26

1.12

5.0

6.7

66.65

69.40

0.30

387

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

273

2157

1.12

1.10

1.1

1.68

4.13

eliau/ml

6.56

919

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

771

1.21

1.10

1.5

1.9

1368.39

11281.36

u/ml

1.24

114

(3012494) Peanut IgE Ab [Units/volume] in Serum

390

1.30

1.10

1.1

0.47

4.21

u/ml

0.97

204

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

160

1641

0.86

1.08

1.1

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

245

1.37

1.08

9.4

7.8

0.35

0.44

umol/l

0.39

221

(3001556) Androgen free Index in Serum or Plasma

1.64

1.08

1.4

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

113

1.57

1.07

4.2

4.7

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

384

0.71

1.07

1.2

1.1

71.24

63.59

u/ml

0.19

372

(3015076) Soybean IgE Ab [Units/volume] in Serum

764

0.80

1.07

1.1

1.0

0.30

0.77

u/ml

0.60

198

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

234

1839

1.13

1.05

1.2

45.57

89.70

u/ml

—

(4146454) Self-monitoring of blood glucose

310

2477

1.11

1.04

2.6

2.7

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

333

2675

1.10

1.02

1.6

1.5

63.38

59.45

1.08

214

1659

(3037692) Legionella sp identified in Specimen by Organism specific culture

102

754

1.20

1.02

1.3

1.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

122

1.53

1.02

1.0

0.02

3.34

u/ml

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

521

0.76

1.01

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

569

5424

0.93

1.01

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

115

1.54

1.01

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

467

3813

1.09

1.01

3.4

3.5

1.23

1.66

2.52

410

3417

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

279

1.33

1.01

1.1

1.4

336674.24

234079.08

nmol/l

0.11

226

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.72

0.98

1.1

1.3

0.49

5.69

u/ml

0.71

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2792

23983

1.04

0.98

3.4

4.4

9.53

29.27

ug/l

9.75

2257

19845

(3003577) Lead [Moles/volume] in Blood

138

1.48

0.97

1.2

1.4

0.12

0.17

umol/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

328

1.30

0.96

11.9

11.7

5.71

5.34

mmol/l

0.31

328

(3007456) Orange IgE Ab [Units/volume] in Serum

1.94

0.96

1.1

1.0

0.07

0.08

u/ml

—

(3026250) Tacrolimus [Mass/volume] in Blood

116

874

1.18

0.95

41.9

39.4

7.07

7.22

ug/l

0.37

104

775

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

595

0.79

0.95

1.6

1.7

1.22

1.60

u/ml

—

163

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.77

0.94

1.1

0.04

u/ml

—

(3042733) HLA Ab [Presence] in Serum

601

1.21

0.92

4.7

4.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

674

1.20

0.92

1.2

1.3

40.97

39.73

g/l

0.35

352

(3024471) HLA-A [Type]

578

1.21

0.90

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

195

0.64

0.90

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

522

1.22

0.90

1.1

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

141

1.45

0.89

1.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

156

1.42

0.89

1.2

1.1

96.00

101.13

titre

0.13

156

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

218

1.34

0.85

1.2

0.54

0.36

u/ml

—

(4133840) Spirometry

486

0.78

0.84

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

121

1.46

0.83

1.0

0.03

0.21

u/ml

—

(21494815) CD4 cells/Lymphocytes in Specimen

209

1661

1.12

0.83

2.3

2.2

40.19

37.87

1.50

204

1633

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

337

3246

0.92

0.83

3.2

3.7

25.57

43.45

u/ml

3.54

324

3142

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.62

0.82

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

179

0.64

0.81

1.2

1.1

2.05

8.23

u/ml

3.04

179

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.04

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

331

1.26

0.79

2.1

2.9

26.73

59.59

mg/l

—

(3024932) HLA-DR beta [Type]

564

1.19

0.78

1.1

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

153

1.39

0.78

1.5

1.3

1.14

0.97

ml/s/173m2

0.27

103

(3017461) Flecainide [Moles/volume] in Serum or Plasma

116

1.45

0.77

1.2

1.6

0.63

0.83

umol/l

0.76

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.77

0.0

1.0

—

(3016750) Collection duration of Urine

124

1254

0.88

0.76

2.0

2.2

523.47

497.25

min

2.02

914

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

136

1364

0.88

0.74

1.6

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.66

0.74

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

120

0.59

0.73

3.9

3.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

447

1.21

0.73

1.0

8.52

10.99

u/ml

0.43

275

(3010726) Horse dander IgE Ab [Units/volume] in Serum

259

2505

0.92

0.73

1.1

1.40

1.30

u/ml

0.08

142

1284

(21494434) Karyotype in Bone marrow

250

2024

1.10

0.73

1.2

—

(3000012) Reticulocyte production index

422

3491

1.07

0.72

2.0

2.2

0.92

0.89

0.35

299

2436

(3005082) Progesterone [Moles/volume] in Serum or Plasma

484

0.81

0.72

1.3

1.4

28.30

37.39

nmol/l

0.86

431

(3043410) Blood group antigens tested for on Red Blood Cells

579

1.18

0.71

1.7

2.0

—

(3026470) Cobalt [Mass/volume] in Blood

174

1386

1.11

0.70

2.1

2.2

3.24

3.88

ug/l

0.97

159

1286

(3016135) IgD [Mass/volume] in Serum

1.72

0.70

1.1

2.2

26.80

85.46

mg/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

269

2191

1.09

0.69

1.2

1.3

7.20

7.55

mmol/l

1.32

242

1886

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

104

1.45

0.69

1.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

132

1318

0.89

0.69

1.6

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

546

5124

0.94

0.69

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

144

1137

1.12

0.68

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

144

1137

1.12

0.68

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

144

1137

1.12

0.68

1.7

1.8

—

(3025577) Chromium [Mass/volume] in Blood

168

1339

1.11

0.68

2.4

2.2

1.97

2.39

ug/l

1.46

141

1101

(3001218) Citrate [Mass/time] in 24 hour Urine

1.77

0.65

1.6

1.4

291.40

431.88

mg/24h

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

106

824

1.14

0.65

1.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

106

824

1.14

0.65

1.9

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

151

1488

0.90

0.64

1.6

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

107

833

1.14

0.64

1.9

2.0

—

(3001729) Color of Synovial fluid

167

1.33

0.64

1.5

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.57

0.64

1.5

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

534

4477

1.06

0.63

3.9

3.5

27.58

28.32

mg/l

0.19

386

3161

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.70

0.62

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.70

0.62

1.8

3.7

—

(3012565) Volume of 24 hour Urine

133

1053

1.12

0.62

1.7

2.2

2095.27

1907.23

1.16

110

924

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

215

1.28

0.62

1.1

0.21

5.92

u/ml

1.30

146

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

143

1138

1.11

0.61

1.7

1.8

—

(40768441) Liver Pathology biopsy report

159

1556

0.90

0.61

1.7

1.3

—

(44786800) Granulocytes/Leukocytes in Body fluid

307

0.78

0.61

1.6

1.3

28.00

25.18

0.19

238

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.61

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.60

0.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

108

1.39

0.59

1.6

1.3

362.88

317.46

umol/24h

0.34

108

(3042631) Mycobacterium sp identified in Specimen

334

3162

0.94

0.59

2.8

2.7

—

(40765096) Chromosome analysis panel by Banding

681

0.86

0.58

1.2

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

0.58

0.0

1.6

—

19.24

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.44

0.58

1.1

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

314

1.21

0.57

1.1

22.08

35.69

iu/ml

0.92

314

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

143

0.68

0.57

1.0

0.48

0.52

u/ml

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.66

0.56

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

220

1799

1.08

0.56

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

300

1.21

0.54

4.4

5.8

40.48

45.25

ug/min

0.23

249

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

145

1167

1.10

0.53

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.60

0.52

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

180

0.74

0.51

3.4

2.7

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

143

1.30

0.50

1.5

1.6

1.68

0.73

0.83

110

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

132

1286

0.91

0.50

1.3

136.88

175.79

pmol/l

2.72

132

1286

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.44

0.49

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

364

0.83

0.48

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

370

1.17

0.48

1.8

1.6

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

264

1.21

0.48

3.1

2.7

89.96

75.83

pmol/l

0.15

231

(3035715) Granulocytes [#/volume] in Blood

403

3759

0.95

0.47

3.4

3.2

4.56

4.18

e9/l

2.18

403

3751

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

462

1.15

0.47

1.1

885.71

923.71

titre

0.09

(3009677) Dengue virus Ab [Presence] in Serum

1.48

0.47

1.1

1.2

—

(3007733) Chloride [Moles/volume] in Urine

1.41

0.45

1.0

1.2

79.00

81.22

mmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

225

1867

1.07

0.43

2.3

2.4

26.43

24.72

iu/ml

0.11

227

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.64

0.43

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

548

0.87

0.43

3.7

3.6

8.53

8.13

mg/l

0.18

444

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.58

0.42

1.0

1.1

2900.00

1881.07

titre

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.63

0.42

1.2

1.1

7.78

8.47

mmol/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.39

0.42

1.8

2.2

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.53

0.41

1.0

1.1

—

371.20

—

(3007916) DNA double strand Ab [Titer] in Serum

229

1.20

0.40

1.6

1.3

102.00

209.63

titre

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

218

2056

0.94

0.40

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

270

1.18

0.40

1.2

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

195

1845

0.94

0.40

1.1

1.0

0.12

0.39

u/ml

1.89

622

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

141

1.26

0.39

2.7

5.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

222

1.20

0.39

1.1

1.0

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

242

2025

1.06

0.38

1.7

1.5

24.09

29.18

1.58

152

1217

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2894

25257

1.02

0.38

5.3

5.1

32.75

32.71

0.05

1935

16523

(46235168) Fasting glucose [Moles/volume] in Blood

218

0.81

0.36

1.9

2.5

7.43

7.32

mmol/l

0.05

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

237

0.82

0.36

1.9

1.8

—

(3022475) Manganese [Moles/volume] in Blood

103

1.29

0.36

1.1

1.3

0.17

0.15

umol/l

0.61

103

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

151

1.23

0.36

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

160

1.22

0.34

1.1

—

0.43

—

(3000285) Sodium [Moles/volume] in Blood

425

1.13

0.34

1.4

1.2

138.43

138.25

mmol/l

0.09

353

(3008536) Aspergillus sp Ab [Presence] in Serum

459

1.12

0.34

2.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.36

0.33

1.3

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

808

1.09

0.33

2.1

2.4

19.92

357.81

ug/l

1.80

774

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

137

1.23

0.32

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

114

1088

0.93

0.32

1.6

1.5

3.76

3.41

0.08

239

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

402

0.88

0.31

1.1

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.70

0.31

46.9

9.0

106.71

105.24

g/l

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

189

1769

0.95

0.31

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

122

1008

1.07

0.30

2.2

2.1

254.41

89.50

ug/min

0.41

226

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

109

898

1.08

0.30

1.6

2.1

38.55

39.99

g/l

1.38

109

898

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

525

1.10

0.28

1.7

10.11

9.22

ug/l

0.73

525

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

218

1841

1.05

0.28

1.9

4.16

4.03

mg/l

0.17

206

1768

(3017181) Myelocytes/Leukocytes in Blood

2224

19434

1.02

0.28

4.5

4.3

0.95

0.98

0.25

780

6162

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

619

1.09

0.28

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

370

0.89

0.27

1.2

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

500

0.90

0.27

2.7

147.69

151.13

au/ml

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

748

0.92

0.27

1.2

1.3

478.98

284.65

ug/l

0.17

411

(3011544) Albumin [Mass/volume] in Pleural fluid

266

0.87

0.26

1.2

16.06

17.20

g/l

0.26

248

(4038314) Semen analysis, post vasectomy

0.70

0.26

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

288

2651

0.96

0.25

1.1

0.64

1.02

u/ml

1.26

130

1165

(40768446) Kidney Pathology biopsy report

811

1.07

0.25

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

157

1322

1.05

0.24

2.0

2.5

0.69

0.67

e9/l

0.07

148

1248

(40765089) Chromosome analysis panel - Blood by G-banded

357

0.89

0.24

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

150

0.83

0.24

1.1

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.34

0.23

1.4

1.1

296.60

275.52

u/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

114

1070

0.94

0.23

1.1

20.19

19.00

u/ml

0.12

402

(3035320) C reactive protein [Mass/volume] in Body fluid

192

1629

1.04

0.23

3.6

2.6

29.48

30.67

mg/l

0.16

136

1195

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.27

0.22

4.6

5.9

0.45

0.25

mmol/l

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.73

0.22

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1096

9874

0.98

0.22

2.8

4.0

63.26

67.17

u/ml

0.10

1042

9547

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.25

0.22

3.6

4.1

24.36

18.01

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

169

1.15

0.21

1.2

1.5

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.21

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

270

0.89

0.21

2.9

2.7

—

(3045142) Bone marrow Pathology biopsy report

301

2582

1.03

0.21

1.3

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

44.35

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

672

1.07

0.21

1.4

21.06

20.74

0.04

599

(3001893) Eosinophils/Leukocytes in Pleural fluid

756

0.94

0.21

1.5

1.4

4.04

2.59

0.56

630

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

119

1001

1.05

0.20

4.8

3.4

1.33

1.30

0.05

119

1001

(3041672) Baker's yeast Ab [Presence] in Serum

1.22

0.20

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.25

0.20

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

196

1.13

0.19

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

225

2064

0.97

0.19

1.1

3.24

4.01

u/ml

0.33

107

902

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

752

0.94

0.18

1.3

1.2

9.55

11.46

mm/h

0.74

752

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.17

0.18

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

133

1130

1.04

0.17

3.8

—

(3009015) Lactate [Moles/volume] in Synovial fluid

233

1.10

0.16

1.1

1.3

6.94

6.62

mmol/l

0.09

113

(3014133) Dog dander IgE Ab [Units/volume] in Serum

239

2180

0.97

0.16

1.1

2.77

3.33

u/ml

0.24

129

1070

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

243

1.09

0.14

2.6

3.4

1.10

1.31

mg/l

0.43

190

(3033099) Centromere Ab [Titer] in Serum

507

0.94

0.13

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

125

1.13

0.13

1.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

342

3092

0.98

0.13

1.7

1.9

25.96

25.89

ug/l

0.00

334

3029

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

178

0.90

0.13

1.2

6.12

6.14

mmol/l

0.03

178

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.85

0.13

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

379

0.93

0.13

1.7

1.8

1.79

2.33

ug/l

0.83

226

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

194

1.10

0.12

1.2

1.1

6.25

20.66

iu/ml

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

160

1.11

0.12

1.8

2.0

10.29

17.77

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

263

1.08

0.12

1.1

18.73

19.96

u/l

0.16

171

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

556

0.96

0.10

2.2

2.0

8.79

9.01

mg/l

0.12

462

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

395

1.05

0.10

3.6

5.4

55.51

54.62

u/l

0.02

386

(3006598) pH of Arterial cord blood

1.14

0.10

1.0

1.1

—

(3002179) Metamyelocytes/Leukocytes in Blood

2100

18500

1.01

0.09

4.1

4.2

0.67

0.73

0.57

737

5867

(3013466) aPTT in Blood by Coagulation assay

1.13

0.09

1.0

1.1

39.14

38.28

0.08

(3013762) Body weight Measured

1.03

0.09

1.4

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

877

0.97

0.09

1.0

1.1

1.33

1.32

u/ml

0.00

276

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.11

0.09

1.2

1.1

36.42

31.61

mg/24h

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.79

0.08

4.8

8.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

327

0.95

0.08

1.8

1.5

0.57

0.51

e9/l

0.61

327

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

565

1.04

0.07

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.04

0.07

1.1

—

(40763590) HLA-DQ beta [Type]

1.04

0.07

1.0

—

(40760410) HLA-B [Type] by High resolution

1.03

0.07

1.0

—

(40760409) HLA-A [Type] by High resolution

1.03

0.07

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.03

0.07

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

602

1.03

0.06

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

602

1.03

0.06

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

602

1.03

0.06

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

602

1.03

0.06

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

363

3185

1.01

0.05

1.2

1.1

1.14

1.86

u/ml

1.67

215

1713

(3038515) Glucose [Moles/volume] in Venous blood

526

4625

1.01

0.05

4.6

3.3

7.56

7.70

mmol/l

0.47

516

4517

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

110

993

0.98

0.05

5.8

5.6

5853.71

4617.69

u/ml

0.07

154

(3020650) Glucose [Presence] in Urine

680

0.98

0.05

1.8

1.6

0.12

0.03

estimate

0.68

680

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

202

1.05

0.05

2.1

54.46

61.99

0.33

137

(4211845) Urine protein measurement

116

1044

0.98

0.04

3.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.08

0.04

1.2

1.8

—

(3025159) Blasts/Leukocytes in Blood

2103

18682

1.00

0.04

4.8

4.5

0.15

0.33

1.45

619

5089

(3014599) Egg white IgE Ab [Units/volume] in Serum

856

0.98

0.04

1.1

1.0

2.12

2.04

u/ml

0.02

208

(3003694) ABO and Rh group [Type] in Blood

6211

55095

1.00

0.03

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

151

1.06

0.03

2.4

2.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

113

0.94

0.02

1.4

1.2

—

(3002256) Pathology report gross observation

3202

28340

1.00

0.02

1.4

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

2096

18594

1.00

0.02

4.5

4.4

0.09

0.12

1.55

652

5356

(3006462) Nitrate [Presence] in Urine

107

957

0.99

0.01

3.3

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

139

0.96

0.01

2.1

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

327

2907

1.00

0.01

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

792

1.01

0.00

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

309

2732

1.00

0.00

1.1

4.16

4.43

u/ml

0.13

174

1411

(3011335) Digoxin [Mass/volume] in Serum or Plasma

181

1.03

0.00

2.4

2.2

0.66

0.65

ug/l

0.01

181

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.98

0.00

8.8

9.3

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

220

1.01

0.00

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

125

0.99

0.00

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

527

1.01

0.00

2.2

1.8

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

360

1.01

0.00

6.0

3.1

228.78

101.61

ng/l

0.48

149

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

270

0.98

0.00

1.1

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

285

0.99

0.00

1.6

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

873

1.00

0.00

1.4

61.34

63.78

0.28

714

(3034092) Cytoplasmic Ig cells/cells in Blood

243

0.98

0.00

7.7

9.0

0.20

0.22

0.10

243

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

257

1.00

0.00

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

146

0.97

0.00

1.6

1.5

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

35.50

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.87

-0.00

1.0

1.1

0.01

1.45

u/ml

—

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.7

—

4.71

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.82

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

1.01

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_COGNITIVE_FUNCTIONS_AWARE – Other symptoms and signs involving cognitive functions and awareness

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other symptoms and signs involving cognitive functions and awareness

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other symptoms and signs involving cognitive functions and awareness (R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_COGNITIVE_FUNCTIONS_AWARE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints